Liste non exhaustive de références
bibliographiques
(mise à jour : 7 octobre 2002)
|
DERNIERES REFERENCES MISES EN LIGNE (7 octobre 2002) Campbell C., MacPhail C. (2002). Peer education, gender and the development of critical consciousness: participatory HIV prevention by South African youth. Social Science & Medicine, 55 (2): 331-345. [Abstract]. Capaldi D.M., Stollmiller M., Clark S., Owen L.D. (2002). Heterosexual risk behaviors in at-risk young men from early adolescence to young adulthood: prevalence, prediction, and association with STD contraction. Developmental Psychology 2002, 38 (3): 394-406. [Abstract]. Crosby R., DiClemente R.J., Holtgrave D.R., Wingood G.M. (2002). Design, measurement, and analytical considerations for testing hypotheses relative to condom effextiveness against non-viral STIs. Sex Transm Infect, 78: 228-231. Des
Jarlais D.C., Semaan S. (2002). HIV Prevention Research: Cumulative
Knowledge or Accumulating Studies? Eke A, Peersman G., Semaan S., Hylton K., Kiiti N., Sweat M.D. (2002). Acquisition and Review of Non-U.S.–Based HIV Risk Reduction Intervention Studies. JAIDS, 30: S51-S55.[Accès au numéro online présentant l'article complet]. Elwy A.R., Hart G.J., Hawkes S., Petticrew M. (2002). Effectiveness of interventions to prevent sexually transmitted infection and human immunodeficiency virus in heterosexual men. A systematic review. Arch Intern Med, 162 (16): 1818-1830. [Abstract] [Full text]. Fenton K.A. , Chinouya M., Davidson O., Copas A. (2002). HIV testing and high risk sexual behaviour among London’s migrant African communities: a participatory research study. Sex Transm Infect, 78: 241-245. [Abstract] Greco M., Brownlea A., McGovern J. (2001). Impact of patient feedback on the interpersonal skills of general practice registrars: results of a longitudinal study. Medical Education, 35 (8), 748-756. [Abstract]. Hedges L.V., Johnson W.D., Semaan S., Sogolow E. (2002). Theoretical Issues in the Synthesis of HIV Prevention Research. JAIDS, 30: S8-S14.[Accès au numéro online présentant l'article complet]. Hobfoll S.E., Jackson A.P., Lavin J., Johnson R.J., Schroder K.E.E.E. (2002). Effects and generalizability of communally oriented HIV-AIDS prevention versus general health promotion groups for single, inner-city women in urban clinics. Journal of Consulting and Clinical Psychology, 70 (4): 950-960. [Abstract]. Hugen P.W.H., Langebeek N., Burger D.M., Zomer B., van Leusen R. et al. (2002). Assessment of Adherence to HIV Protease Inhibitors: Comparison and Combination of Various Methods, Including MEMS (Electronic Monitoring), Patient and Nurse Report, and Therapeutic Drug Monitoring. JAIDS, 30 (3): 324-334. [Abstract]. Kanshana S., Simonds R.J. (2002). National program for preventing mother–child HIV transmission in Thailand: successful implementation and lessons learned. AIDS, 16 (7): 953-959. [Abstract]. Kresina T.F., Flexner C.W., Sinclair J., Correia M.A., Stapleton J.T., et al. (2002). Alcohol use and HIV pharmacotherapy. AIDS Research and Human Retroviruses, 18 (11): 757-770. [Abstract]. Leigh B.C. (2002). Alcohol and condom use. A meta-analysis of event-level studies. Sexually Transmitted Diseases, 29 (8): 476-482. [Abstract]. Miles K. (2002). The historical role and education of nurses for the care and management of sexually transmitted infections in the United Kingdom: 1 Role. Sex Transm Inf 2002, 78 (4): 292-297. [Abstract]. Miles
K. (2002). The historical role and education of nurses for the care
and management of sexually transmitted infections in the United Kingdom:
Education and training. Sex Transm Inf 2002, 78 (4): 298-301. [Abstract]. Neumann M.S., Johnson W.D., Semaan S., Flores S.A., Peersman G., Hedges L.V., Sogolow E. (2002). Review and Meta-analysis of HIV Prevention Intervention Research for Heterosexual Adult Populations in the United States. JAIDS, Supplement 1, 30 (0): S106-S117. [Accès au numéro online présentant l'article complet]. Okubagzhi G., and Singh S. (2002). Etablishing an HIV/AIDS programme in developing countries: the Ethiopan experience. AIDS 2002, 16 (12) : 1575-1586. [Abstract]. Powderly W.G. (2002). Sorting through confusing messages : the art of HAART. JAIDS, 31 : S3-S9. del Rio C., Sepulveda J. (2002). AIDS in Mexico: lessons learned and implications for developing countries. AIDS, 16 (12): 1445-1457. [Abstract]. Smith T.W., Kendall P.C., Keefe F.J. (2002). Behavorial medicine and clinical health psychology: Introduction to the special issue, a view from the decade of behavior. Journal of Consulting and Clinical Psychology, 70 (3): 459-462. [Abstract]. *Sogolow E., Peersman G., Semaan S., Strouse D., Lyles C.M.(2002). The HIV/AIDS Prevention Research Synthesis Project: Scope, Methods, and Study Classification Results. JAIDS, Supplement 1, 30 (0): S15-S29.[Accès au numéro online présentant l'article complet]. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PSYCHOLOGIE
MEDICALE
|
|
|
COMMUNICATION
|
|
Barroso J. (1999). Long-term nonprogressors with HIV disease. Nursing research, Vol. 48 (5): 242-249.
Brashers D.E., Neidig J.L., Cardillo L.W.(1999). ‘In an important way, I did die’ : uncertainty and revival in persons living with HIV or AIDS. AIDS Care, Vol.11(2): 201-219.
Brashers D.E., Neidig J.L., Reynolds N.R., Haas S.M. (1998). Uncertainty in illness across the HIV/AIDS trajectory. Journal of the Association of Nurses in AIDS Care, Vol. 9 (1): 66-77.
Carricaburu D., & Pierret J. (1995). From biographical disruption to biographical reinforcement : the case of HIV-positive men. Sociology of Health & Illness, 17(1): 65-88.
Carstensen L.L., Fredrickson B.L. (1998). Influence of HIV status and age on cognitive representations of others. Health Psychology, Vol. 17 (6): 494-503.
Chapman L. (1998). Body image and HIV : implications for support and care. AIDS Care, Vol. 10, Supplement 2: S179-S189.
Charles D., Miné M., Rodriguez C. (1999). Le sida et le droit du travail. Les Editions de l’Atelier & Les Editions Ouvrières.
Chesney M.A., Folkman S. (1994). Psychological impact of HIV disease and implications for intervention. Psychiatric Clinics of North America, Vol. 17 (1): 163-182.
Chidwick A., Borrill J. (1996). Dealing with a life-threatening diagnosis : the experience of people with the human immunodeficiency virus. AIDS Care, Vol. 8 (3) : 271-284.
Crossley M.L. (1998). ‘Sick role’ or ‘empowerment’ ? The ambiguities of life with an HIV positive diagnosis. Sociology of Health & Illness, Vol. 20 (4): 507-531.
Cunningham W.E., Bozzette S.A., Hays R.D., Kanouse D.E., & Shapiro M.F. (1995). Comparison of Health-Related Quality of Life in Clinical Trial Human Immunodeficiency Virus-Infected Cohorts. Medical Care, 33(4): AS15-AS25.
Dagher E. (2000). Les séropositifs souffrent souvent d’une maladie sociale en plus de leurs problèmes de santé. Info Traitements, 82: 10-11.
Dagher E. (2000). Retour au travail des sidéens : le risque d’une mort sociale programmée. Info Traitements, 79: 1-2.
Davies M.L. (1997). Shattered assumptions : time and the experience of long-term HIV positivity. Social Science & Medicine, Vol. 44 (5): 561-571.
Delor F. (1999). Vie sexuelle des personnes atteintes, sérodiscordance et risque du sida. In: Séropositivité, vie sexuelle et risque de transmission du VIH (85-100). ANRS, Collection Sciences Sociales et Sida.
Emmanuelli J. (2000). Contribution à l'évaluation de la politique de réduction des risques : Les grandes tendances (Tome 1). Edité par l'Institut de Veille Sanitaire (St Maurice, France).
Emmanuelli J. (2000). Contribution à l'évaluation de la politique de réduction des risques : Approche détaillée à l'usage des acteurs de terrain (Tome 2). Edité par l'Institut de Veille Sanitaire (St Maurice, France).
Ezzy D., De Visser R., Grubb I., McConachy D. (1998). Employment, accommodation, finances and combination therapy : the social consequences of living with HIV/AIDS in Australia. AIDS Care, Vol. 10, Supplement 2: S189-S199.
Fabre G. (2000). VIH et Emploi à l’heure des multithérapies : les usages du secret en milieu du travail. Rapport final pour l’ANRS. Publications CNRS, 213 p.
Faucher J.M. (2000). SIDA : Guide des enjeux sociaux. Editions Espaces 34
Gilbert L., Walker L. (2002). Treading the path of leath resistance: HIV/AIDS and social inequalities-a South African case study. Social Science & Medicine, 54: 1093-1110.
Grassi L., Righi R., et al. (1999). Illness behavior, emotional stress and psychosocial factors among asymptomatic HIV-infected patients. Psychotherapy and Psychosomatics, 68: 31-38.
Hirschhorn L., Quinones J., et al. (1998). Highly active antiretroviral therapy in the « real world » : Experiences in an inner-city community health center. 12th World AIDS Conference. Geneva, June. [Abstract #32334].
Holmes W.C., & Shea JA. (1998). A New HIV/AIDS-Targeted Quality of Life (HAT-Qol) Intrument development, Reliability, and Validity. Medical Care, 36(2): 138-154.
Ironson G., Solomon G., Cruess D., Barroso J., Stivers M. (1995). Psychosocial factors related to long-term survival with HIV/AIDS. Clinical Psychology and Psychotherapy, Vol. 2 (4): 249-266.
Kressmann L. (1999). La mobilisation associative. Le Journal du Sida, Numéro Spécial Enfances & Adolescences, 120/121: 44-46.
Laurindo da Silva L. (1999). Vivre avec le SIDA en phase avancée. Paris: L'Harmattan.
Leplège A., Pouchot J., Deslandes J.Y., & Rude N. (1996). Revue des échelles de mesure de qualité de vie utilisée auprès des sujets infectés par le VIH. Revue d'Epidémiologie et de Santé Publique, 44: 23.
Maraschin J. (1999). Homoparentalité et séropositivité. Le journal du Sida, Numéro Spécial Enfances & Adolescences, 120/121: 36.
Meystre-Agustoni G. (1999). Prises de risques chez les personnes vivant avec le VIH/sida. In: Séropositivité, vie sexuelle et risque de transmission du VIH (101-112). ANRS, Collection Sciences Sociales et Sida.
Mill J.E. (2001). I'm not a "Basabasa" women. Clinical Nursing Research, Vol. 10 (3) : 254-274.
Ministère de l’Emploi et de la Solidarité (2000). Infection par le VIH/sida et travail. Paris: CFES, Collection VIH-sida.
Nieuwkerk P.T., Gisolt E.H. et al. (2000). Quality of life in asymptomatic- and symptomatic HIV infected patients in a trial of ritonavir/saquinavir therapy. AIDS, Vol. 14 (2): 181-187.
Nolan E. Penn, et al. (1995). Ethnic minorities, Health care systems and behavior. Health Psychology, 14 (7): 641-646.
Odets W. (1995). In the shadow of the epidemic : being HIV negative in the age of AIDS. Durham: Duke University Press.
ORS Ile-de-France. (2001). Les connaissances, attitudes, croyances et comportements face au VIH/sida en Ile de France. Evolutions 1992-1994-1998-2001. Paris, ORS Ile e France, Coll. VIH/SIDA, Décembre 2001.
Pierret J. (1999). Vie sexuelle et affective des personnes asymptomatiques de longue durée. In: Séropositivité, vie sexuelle et risque de transmission du VIH (71-83). ANRS, Collection Sciences Sociales et Sida.
Prestel T. (1999). AHH* : comment bien compléter son dossier ? Remaides, 34: 34-35 [*Allocation Adulte Handicapé]
Rébillon M., Tourette-Turgis C. (1999). La prise en charge des séropositifs en grande difficulté sociale : reportage à San Francisco dans un centre expérimental sur l’observance. Info Traitements,73: 10-12.
Ross M.W., Hunter C.E. et al. (1994). The mental adjustment to HIV scale : measurement and dimensions of response to AIDS/HIV disease. AIDS Care, Vol. 6 (4): 407-411.
Rotherman-Borus M.J., Lee M.B., Gwadz M., Draimain B. (2001). An intervention for parents with AIDS and their adolescent children. American Journal of Public Health, 91 (8): 1294-1302. [abstract]
Rotheram-Borus M.J., Miller S. (1998). Secondary prevention for youths living with HIV. AIDS Care, Vol. 10(1): 17-34.
Schiltz M.A. (1999). Séropositivité, sexualité et risques. In: Séropositivité, vie sexuelle et risque de transmission du VIH (13-29). ANRS, Collection Sciences Sociales et Sida.
Schwartzberg S.S. (1993). Struggling for Meaning : How HIV-Positive Gay Men Make Sense of AIDS. Professional Psychology : Research and Practice, Vol. 24 (4): 483-490.
Simoni J.M., Mason H.R.C., Marks G. (1997). Disclosing HIV status and sexual orientation to employers. AIDS Care, Vol. 9 (5): 589-599.
Soletti J. (1999). Vous venez à AIDES, qui êtes-vous ? Remaides, 34: 16-17.
Sousa A. (1999). Couples sérodifférents et procréation médicalement assistée. Le journal du Sida, Numéro Spécial Enfances & Adolescences, 120/121: 33-35.
Swindells S., Mohr J. et al. (1999). Quality of life in patients with human immunodeficiency virus infection : impact of social support, coping style and hopelessness. International Journal of STD & AIDS, 10:383-391.
Taylor .ER., Amodei N., Mangos R. (1996). The presence of psychiartic disorders in HIV-infected women. Journal of Counseling & Development, Vol.74: 345-351.
Tourette-Turgis C., Pereira-Paulo L., Rébillon M. (2002). Coopération Nord/Sud - L'arrivée des antirétroviraux: une économie sociale et familiale pertubée, une confrontation à d'impossibles dilemmes. Le Journal de la Démocratie sanitaire, 146: 24-28. [pdf]
Tourette-Turgis C. (2000). De la promesse thérapeutique à la promesse sociale. Info Traitements, 85: 11-12.
Trussler T., Marchand R. (1997). Veiller les uns sur les autres - Guide d'action communautaire - Promotion de la la santé VIH : Théorie, Méthode et Pratique. Vancounver: AIDS Vancouver.
Vosvick M., Gore-Felton C., Koopman C., Thoresen C., Krumboltz J., Spiegel D. (2002). Maladaptive coping strategies in relation to Quality of Life mong HIV+ adults. AIDS and Behavior, 6 (1) : 97-106.
AIDES Fédération Nationale (1999). Les mille et une façon de prendre son traitement. Document du 2 avril 1999.
AIDES Fédération Nationale (1999). Vie quotidienne et traitements de l’infection à VIH. Enquête AIDES/IPSOS, Document du 2 avril 1999.
Anderson R. (2001). A guide to the clinical care of women with HIV/AIDS. U.S. Department of Health and Human Services, Health Resources and Services Administration. (2001, First edition).
Aversa S.L., Kimberlin C., Segal R. (1998). The medication attribution scale : perceived effects of antiretrovirals and quality of life. Quality of Life Research, Vol. 7: 205-213.
Aversa S.L., Kimberlin C. (1996). Psychosocial aspects of antiretroviral medication use among HIV patients. Patient Education and Counseling, 29: 207-219.
Bangsberg D.R., Tulsky J.P., Hecht F.M. et al.. (1997). Protease inhibitors in the homeless. J. of the Amrican Medical Association, 278: 63-65.
Casado A., Consiglio E., Podzamcze D., Badia X. (2001). Highly Active Antiretroviral Treatment (HAART) and health-related quality of life in naive and pretreated HIV-infected patients. HIV Clinical Trials, 2(6): 477-483. [Full Text]
Colebunders R., Schrooten W., Dreezen C., Baratta C., et al. (2001). Antiretroviral treatments used among adults with HIV infection in Europe. AIDS Care, Vol. 13 (1): 5-14
Delfraissy J.F. (2000). (sous la direction de). Rapport sur la prise en charge thérapeutique des personnes infectées par le VIH. [Actualisation du Rapport 1999 - Document accessible sur le site du Ministère délégué à la santé: http://www.sante.gouv.fr/htm/actu/rap_delf/index_delfra00.htm ]
Delfraissy J.F. (1999). (sous la direction de). Prise en charge thérapeutique des personnes infectées par le VIH - Rapport 1999, Recommandations du groupe d'experts. Paris: Médecine-Sciences Flammarion. [Document accessible sur le site du Ministère délégué à la santé:] http://www.sante.gouv.fr/htm/dossiers/sidahop/index_delfra.htm
DiClementi R.J., Funkhouser E., Wingood G., Fawal H., Holmberg S.D., Vermund S.H. (2002). Protease inhibitor combination therapy and decreased condom use among gay men. South Med J., 95(4): 421-425 [Abstract]
Duran S., Saves M., Spire B., Cailleton V., Sobel A., Carrieri P., Salmon D., Moatti J.P., Leport C., The APROCO Study Group. (2001). Failure to maintain long-term adherence to highly active antiretroviral therapy : the role of lipodystrophy. AIDS, 15 (18): 2441-2444. [Abstract]
Farber E.W., McDaniel S. (1999). Assessment and psychotherapy practice implications of new combination antiviral therapies for HIV disease. Professional Psychology: Research and Practice, 30 (2): 173-179.
Flaskerud J.H. (1995). HIV/AIDS : a guide to nursing care. Philadelphia: W.B. Saunders, 405-432.
Folkman S., Chesney M.A. (1995). Coping with HIV Infection. In: M. Stein, P. Baum (Eds.), Chronic diseases: Perspectives in behavorial medicine (115-133), Mahwah, NJ: Erlbaum.
Gerber B., Love C., Caspers N. et al. (1999). « Making all the difference in the world : How physicians can help HIV-seropositive patients become more involved in their healtcare. AIDS Patient Care and STDs, Vol. 13 (1): 29-39.
Gilden D. (1999). Protease inhibitors, sexual dysfunction and Viagra. Treatment Issues, Vol. 13 (3): 12.
Grabar S., Pradier C., Le Corfec E. et al. (2000). Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor. AIDS, Vol. 14(2): 141-149.
Justice A.C., Holmes W., Gifford A.L. et al. (2001). Development and validation of a self-completed HIV symptom index. Journal of Clinical Epidemiology, 54: S77-S90.
Lenderking W.R., Gelber R.D. et al. (1994). Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The New England Journal of Medicine, Vol. 330 (11): 739-743.
Lin M.K., Wu A.W., Revicki D.A. (2002). Incorporating quality of life measures in HIV clinical trials. HIV Clinical Trials, 3(3): 202-218. [Full Text]
Lori F., Lisziewicz J. (2001). Structured treatment interruptions for the management of HIV infection. JAMA, Vol. 286: 2981-2987 [Abstract], [Full Text]
Malafronte B., Perbost I., Dunais B., et al. (1999). Unconventional medicine and AIDS : Trends in behavior among patients receiving protesase inhibitors. 12th World AIDS Conference. Geneva, June. [Abstract #14119].
Malsan S. (2002). Les tradipraticiens, un réel espoir pour l'Afrique. Le Journal de la Démocratie sanitaire, N° 142 : 30-32.
March F., Garriga X., Rodriguez P., Moreno C., Garrigo M., Coll P., & Prats G. (1997). Acquired drug resistance in Mycobacterium tuberculosis isolates recovered from compliant patients with human immunodeficiency virus-associated tuberculosis. Clinical Infectious Diseases, 25 (5): 1044-7.
Mathews W.C., Mar-Tang M., Ballard C., Colwell B., Abulhoso K., Noonan C., Barber R.E., Wall T.L. (2002). Prevalence, predictors, and outcomes of early adherence after starting or changing antiretroviral therapy. AIDS Patients Care STDS, 16 (4): 157-172. [Abstract]
Morgenstern T.T., Grimes D.E., Grimes R.M. (2002). Assessment of readiness to initiate antiretroviral therapy. HIV Clinical Trials, 3 (2): 168-172. [Full Text]
Msellati P., Vidal L., Moatti J.P. (sous la direction) (2001). L'accès aux traitements du VIH/SIDA en Côte d'Ivoire. Paris : ANRS, Coll. Sciences Sociales et Sida.
Meystre-Agustoni G., Dubois-Arber F. Cochand P. & Telenti A. (2000). Antiretroviral therapies from the patient's perspective. AIDS Care, Vol.12 (6): 717-721
Ministère de l’Emploi et de la Solidarité (1999). Traitement de l’infection à VIH. Antirétroviraux : prescription, dispensation et prise en charge. Paris: CFES, Collection VIH-sida, 2ème édition.
Ministère de l’Emploi et de la Solidarité (1999). Guide pratique des antirétroviraux - " Prendre un médicament c’est toute une histoire". Paris: CFES, Collection VIH-sida, 2ème édition.
Morin M. (2001). Croyances, attitudes et représentations sociales dans la prévention et le traitement de l'infection au VIH. In: M.L. Bruchon-Schweitzer, B. Quintard (Eds.), Personnalité et maladie (239-258), Paris: Dunod.
Moyle G.J., Gazzard B.G. (1999). A risk-benefit assessment of HIV protease inhibitors. Drug Safety, Vol. 20 (4): 299-321.
Peytavin G., Certain A., Rebillon M. (1999). Dosages : ajuster le traitement pour chaque patient. Info Traitements, Numéro Spécial Observance, 64/65: 14-17.
*Powderly W.G. (2002). Sorting through confusing messages : the art of HAART. JAIDS, 31 : S3-S9.
Royer E.S., Weibel N., Bonin B., Dobracheff C., Laurent R. (2000). Vers un meilleur vécu des traitements. Le Journal du Sida, 123: 13-14.
Tourette-Turgis C., Rébillon M. (2001). Infection par le VIH - Accompagnement et suivi des personnes sous traitement antirétroviral. Paris: Comment Dire.
Tourette-Turgis C. (2000). De la promesse thérapeutique à la promesse sociale. Info Traitements, 85: 11-12.
Trénado E., Prestel T. (1999). Peut-on interrompre son traitement anti-VIH ? Remaides, 34: 28-29.
Treisman G.J., Angelino A.F., Hutton H.E. (2001). Psychiatric issues in the management of patients with HIV infection. JAMA, 286 (22): 2857-2864.
Tuomala R.E., Shapiro D.E., Mofenson L.M., Bryson Y., Culnane M., Hughes M.D., O'Sullivan M.J., Scott G., Stek A.M., Wara D., Bulterys M. (2002). Antiretroviral therapy during pregnancy and the risk of an adverse outcome. The New England Journal of Medecine, 346 (24): 1863-1870. [Abstract]
Vosvick M., Gore-Felton C., Koopman C., Thoresen C., Krumboltz J., Spiegel D. (2002). Maladaptive coping strategies in relation to Quality of Life mong HIV+ adults. AIDS and Behavior, 6 (1) : 97-106.
OBSERVANCE TRAITEMENTS CONTRE LE VIH/sida
American Psychological Association. (1997). Adherence to HIV/AIDS drug therapy. Testimony of the American Psychological Association submitted to the United States Senate – Committee on Labor and Human Resources, October 30. http://www.apa.org
"Adherence to HIV/AIDS Drug therapy", Testimony of The American Psychological Association submitted to the United States Senate Committee on Labor and Human Resources, Octobre 30, 1997
Altice FL., Mostashari F., Thompson AS., et al. (1997). Perceptions, acceptance and adherence to antiretrovirals among prisoners. Proceedings of the 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, Jan. 22-26, 1997. Abstract #253.
Arras JD. (1990). Non compliance in Aids Research. Hastings center report, 20(5): 24-32.
Aversa SL., Kimberli C. (1996). Psychosocial aspects of antiretroviral medication use among HIV patients. Patient Education and Counseling, 29: 207-219.
Bachiller P., Arrando FR., Liceaga G., et al. (1998). Adherence to antiretroviral therapy in HIV-infected persons. 12th World AIDS Conference. Geneva, June. [abstract #32392].
Bailey A., et al. (1995). Factors affecting an individuals ability to administer medication. Home Healthcare Nurse, 13 (5): 57-63.
Bamberger JD. (1999). Novel HIV Medication Adherence Support Program in San Francisco. Draft du 22 septembre (non publié – 5 p.).
Bangsberg DR., Hecht FM., Charlebois ED., et al.. (2000). Adherence to protease inhitors, HIV-1 load, and development of drug resistance in an indigent population. AIDS, 14: 357-366.
Bangsberg DR., Moss A. (1999). When should we delay highly active antiretroviral therapy? J Gen Intern Med, 14: 446-448.
Bangsberg DR., Zolopa AR., Charlebois E., et al. (1998). HIV-infected homeless and marginally housed (H/M) patients adhere to and receive early virologic benefit from protease inhibitors (PI). Proceedings of the 5th Conference on Retroviruses and Opportunistic Infections, Chicago, I11, Feb. 1-5, 1998. Abstract #152.
Baron B., Tourette-Turgis C., Rebillon M. (1999). Monitoring électronique de l'adhésion à un traitement VIH par antirétroviral dispensé dans une pharmacie de ville. [diapositives] Présentation des résultats d'une étude sur le suivi d'observance en pharmacie de ville, Novembre 1999.
Baylac M., Guessant S., Tabti K., Cousin P. (2000). Un modèle de feuille "conseil aux patients" pour la prise des antirétroviraux. Journal de Pharmacie Clinique, 19(3): 223-229.
Becker M.H., Maiman L.A. (1980). Strategies for enhancing patient compliance. Journal of Community Health, 6: 113-115.
Becker, et al. (1978). Compliance with a Medical Regimen for Asthma. Public Health Reports, 93: 268-277.
Becker M.H., & Maiman LA. (1975). Sociobehavioral Determinants of compliance with Health and Medical care. Medical Care, 13 (1): 10-24.Beechem M.H. (1995). Developing a culturally-sensitive treatment : plan in pre-hospice South Texas. Hospice Journal, 10 (2): 19-34.
Bentz L., Pradier C., Tourette-Turgis C., Morin M., Rébillon M. et al. (2001). Description et évaluation d'un programme d'intervention sur l'observance thérapeutique (counseling) dans un centre hospitalo-universitaire. In : Ed. ANRS : L'observance aux traitements contre le VIH : Mesure, déterminants, évolution. Collection Sciences Sociales et Sida, Décembre 2001: 99-112.
Bentz L., Pradier C., Tourette-Turgis C., Rébillon M., Morin M., et al.. (2001). Impact of a counseling program on treatment adherence in HIV infected persons treated by HAART in a French University Hospital. Fifth International Conference AIDS IMPACT 2001, Biopsychosocial aspects of HIV infection, Brighton, United Kingdom, July 8-11, 2001. (Oral presentation, July 9). [diapos en anglais]
Besch C.L. (1995). Compliance in clinical trials. AIDS, 9 (1): 1-10.
Bessette D., Rebillon M. (1999). La direction Générale de la Santé et l’observance – Définir des recommandations applicables. Info Traitements, Numéro Spécial Observance, 64/65 : 25-26.
Blumenfield M., Milazzo J., Wormser GP. (1990). Noncompliance in hospitalized patients with AIDS. General Hospital Psychiatry, 12: 166-169.
Bogart L.M., Catz S.L., Kelly, J.A., et al. (2001). Factors influencing physicians'judgments of adherence and treatment decisions for patients with HIV disease, Med. Decis Making, 21(1): 28-36.
Boitel-Stein R., Tourette-Turgis C. (1999). Libérer la parole sur les traitements : parler des effets secondaires et des problèmes d’observance dans un groupe de personnes en trithérapie. Info Traitements, Numéro Spécial Observance, 64/65: 31-32.
Bond N.S., et al. (1991). Detection methods and strategies for improving medication compliance. AJPH, 48: 1978-1998.
Botello J., Dudrak R. (1992). Home assessment of adherence to long-term medication in the elderly. J Fam Pract, 35: 61-65.
Brandimonte M.A et Passolunghi M.A (1994). The effect of cue-familiarity, cue-distinctiveness, and retention interval on prospective remembering. Quaterly Journal of Experimental Psychology, 47 A(3) : 566-587.
Breton C., Tourette-Turgis C. (1999). Docteur, j’adhère au traitement… mais j’oublie. Info Traitements, Numéro Spécial Observance, 64/65 : 20-21.
Brigido L.F., Veiga A.P., et al. (1998). Low adherence in antiretroviral users at Sao Paolo, Brazil. 12th World AIDS Conference. Geneva, June. [Abstract #32370].
Broers B, Morabia A, et al. (1998). A Cohort Study of Drug Users' Compliance with Zidovudine Treatment. Arch Intern Med, 154(10):1121-7.
Brown C.M. (1998). Use of alternative therapies and their impact on compliance : Perceptions of community pharmacists in Texas. Journal of the American Pharmaceutical Association, Vol. 38 (5) :603-607.
Brown M.A., Inouye J., Powell-Cope G.M. et al. (1998). Social support and adherence in HIV+ persons. 12th World AIDS Conference. Geneva, June. [Abstract #32346].
Burgos M., Revsin N.S. et al. (1998). Obstacles in treatment adherence : Patients reasons. 12th World AIDS Conference. Geneva, June. [Abstract #32400].
Celentano D.D., Vlahov D., Cohn S., et al. (1998). Self-reported antiretroviral therapy in injection drug users. JAMA, August 12, 280 (6): 545-546.
Cheever L.W. (2001). Adherence to HIV therapies. In : A guide to the clinical care of women with HIV/AIDS, (139-148), U.S. Department of Health and Human Services, Health Resources and Services Administration (2001, First Edition).
Cheever L.W., Kervly J.C., Moore R.D. (1999). Antiretroviral use and adherence predicted by active illicit drug use. 39th Interscience Conference on Antimicrobial Agents and Chemotheray. San Francisco, September. [Abstract #596].
Cherabi K., Tourette-Turgis C. (1999). Suivre des personnes en grande difficulté sociale. Infos Traitements, Numéro Spécial Observance, 64/65: 33-34.
Chesney M.A., Morin M., Sherr L. (2000). Adherence to HIV combination therapy. Soc. Sci. Med., 50(11): 1599-1605.
Chesney M.A., Ickovics J.R., Chambers D.B. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials : the AACTG adherence instruments. AIDS Care, Vol. 12 (3): 255-266.
Chesney M.A., Ickovics J., Hecht F.M., et al. (1999). Adherence: a necessity for successful HIVcombination therapy. AIDS, 13: S271-S278.
Chesney M.A., Tourette-Turgis C. (1999). Partenariat médecin/patient : gérer soi-même son traitement. Info Traitements, Numéro Spécial Observance, 64/65: 12-13.
Chesney M.A. (1997). Compliance : how you can help. HIV Newsline, 4(3): 67-72
Chesney M.A., Folkman S., Chambers D. (1996). Coping effectiveness training for men living with HIV : preliminary findings. International Journal of STD & AIDS, 7 (Suppl. 2): 75-82
Chesney M.A., Folkman S. (1994) "Psychological impact of HIV disease and implications for intervention", Psychiatric Clinics of North America, 17 (1): 163-182.
Chow R., Chin T., Fong I.W., Bendayan R. (1993). Medication use patterns in HIV-positive patients. Canadian Journal of Hospital Pharmacy, 46 (4): 171-175
Cook R.L., Sereika S.M., Woodward W.C., et. al. (2001). Problem drinking and medication adherence among persons with HIV infection. J. Gen.Intern. Med., 16( 2): 83-88.
Corless I.B., Holzemer W.L., Turner J.G., et al. (1998). Cognition and HIV adherence. Proceedings of the 12th World AIDS Conference, Geneva, Switzerland, June 28-July 3, 1998. Abstract #32387.
Costagliola D. Barberousse C. (2001). Comment mesurer l'observance ? In : Ed. ANRS : L'observance aux traitements contre le VIH : Mesure, déterminants, évolution. Collection Sciences Sociales et Sida, Décembre 2001: 33-42.
Courpotin C., Rebillon M. (1999). Gérer le refus du traitement chez l’enfant. Info Traitements, Numéro Spécial Observance, 64/65 : 28-29.
Courpotin C. (1999). Echappement thérapeutique chez des patients adolescents. Action, 63: 10-11.
Crespo-Fierro M. (1997). Compliance/Adherence and Care management in HIV Disease. Journal of the Association of Nurses in AIDS Care, Vol. 8 (4), July-august, 43-54.
Davis M.S. (1966). Variations in patients' Compliance with Doctors' Orders : Analysis of Congruence between Survey Responses and Results of Empirical Investigations. Journal of Medical Education, 41 (11): 1037-1048.
Davis M.S. (1968). Physiological, Psychological and Demographic Factors : Patient Compliance with Doctors' orders. Medical Care, 6: 115-122.
Demas P., et al. (1998). The relationship between HIV treatment acceptance and adherence to psychosocial factors among injecting drug users. AIDS and Behavior, 2 (4): 283-292.
Desclaux A. (2001). L'observance en Afrique : question de culture ou "vieux problème" de santé publique ? In : Ed. ANRS : L'observance aux traitements contre le VIH : Mesure, déterminants, évolution. Collection Sciences Sociales et Sida, Décembre 2001: 57-66.
DiMatteo M.R., Sherboune C.D., Hays R.D., et al. (1993). Physicians'characteristics influence patients'adherence to medical treatment: Results from the medical outcomes study. Health Psychology, 12: 93-102.
Donovan J.L., Blake D.R. (1992). Patient non-compliance: deviance or reasoned decision-making? Soc. Sci. Med., 34: 507-513.
Dunbar-Jacob J. (1990). Predictors of patient adherence : patient characteristics. In: Shumaker SA, Shron E, Ockene JK et al. (Eds.), The Handbook of health behavior change (348-359). New York: Springer Publishing Co.
Dunbar-Jacob J., Burke L.E., Puczynski S. (1990). Clinical assessment and management of adherence to medical regimens. In: S.A. Shumaker, E. Shron, J.K. Ockene, et al. (Eds.). The Handbook of health behavior change (313-339). New York: Springer Publishing Co.
Dunbar-Jacob J., Dwyer K., Dunning E.J. (1991). Compliance with anti-hypertension regimen : A review of the research in the 1980s. Annals of Behavorial Medicine, 13, 31-39.
Dunbar J.M., & Stunkard A.J. (1979). Adherence to diet and drug regimen. In: R. Levy, B. Rifking, B. Dennis, et al. (Eds.), Nutrition, Lipids and Coronary Heart Disease (391-423), New York: Raven Press.
Duran S., Saves M., Spire B., Cailleton V., Sobel A., Carrieri P., Salmon D., Moatti J.P., Leport C., The APROCO Study Group. (2001). Failure to maintain long-term adherence to highly active antiretroviral therapy : the role of lipodystrophy. AIDS, 15 (18): 2441-2444. [Abstract]
Duran S., Spire B., Raffi F., et al. (2001). Self-reported symptoms after initiation of a protease inhibitor in HIV-infected patients and their impact on adherence to HAART. HIV Clinical Trials, 2(1): 38-45 [Abstract]
Eldred L., Wu A., Chaisson R.E., et al. (1997). Adherence to antiretroviral therapy in HIV disease. Proceedings of the 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, Jan. 22-26, Abstract #251.
El-Sadr W., Medard F., Barthaud V. (1993). Directly observed therapy for tuberculosis: The Harlem Hospital experience. American Journal of Public Health, 86: 1146-1149.
Eraker S.A., Kirst J.P., Becker M. H. (1984). Understanding and improving patient compliance. Annals of International Medecine, 100: 258-268.
Escaffre N., Morin M., Bouhnik. A.D. (2000). Injecting drug users'adherence to HIV antiretroviral treatments: physicians'beliefs. AIDS Care, 12 (6): 723-730.
Faure J. (1998). Les programmes d'aide à l'observance : Premier bilan. Le Journal du Sida,105-106: 20-23.
Fogarty L., Roter D., Larson S., Burke J., Gillespie J., Levy R. (2002). Patient adherence to HIV medication regimens: a review of published and abstracts reports. Patient Education and Counseling, 46 (2) : 93-108. [abstract]
Folkman, S., Chesney, M.A. (1995). Coping with HIV Infection. In : M. Stein and A. Baum (Eds.), Perspectives on Behavioral Medicine. Hillsdale, NJ: Erlbaum, 115-134.
Ford P.M., Carson R., Pepperell S. (1998) Drug compliance in patients starting saquinavir. 12th World AIDS Conference. Geneva, June. [abstract #60151]
Forum for Collaborative HIV Research (1999). Adherence to HIV Therapy : building a bridge to success. Report from a Workshop, Washington, DC. November 15-16.
Fourney A. (2000). Formative evaluation of an intervention to increase adherence to HIV/AIDS therapies among low-literacy populations. HIV/AIDS Conference. Durban (South Africa), Juillet 2000. [abstract # ThPeB5007].
Freeman R.C., Rodriguez G.M., French J.F. (1996). Compliance with AZT treatment regimen of HIV-seropositive injection drug users: A neglected issue. AIDS Education and Prevention, 8 (1): 58-71.
Frick P.A., Gal P., Lane T.W., et al. (1998). Antiretroviral medication compliance in patients with AIDS. AIDS Patient Care and STDs, 12, 463-470.
Friedland G.H. (1997). Adherence : The Achilles heel of highly active antiretroviral therapy : Improving the management of HIV disease. International AIDS Society-USA, 5: 13-15
Galland J., Block D., (1998). Adherence to antiretroviral regimens in HIV-infected patients: results of a survey among patients and physicians. J Int Assoc Physicians AIDS Care, Vol. 4: 32-35.
Gao X., Nau D. P. , Rosenbluth S.A., Scott V. & Woodward C. (2000). The relationship of disease severity, health beliefs and medication adherence among HIV patients. AIDS Care, Vol. 12 (4): 387-398.
Garrity T.F. (1981). Medical compliance and the clinician-patient relationship : a review. Social Science & Medicine, Vol. 15E : 215-222.
Gifford A.L., Bormann J.E., Shively M.J. et al. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndromes, 23: 386-395.
Gifford A.L., Shively M.J., Bormann D., et al. (1998). Self-reported adherence to combination antiretroviral medication (ARV) regimens in a community-based sample of HIV-infected adults. Proceedings of the 12th World AIDS Conference, Geneva, Switzerland, June 28-July 3, 1998. Abstract #32338.
Gir E., Pratt R., Bunch E.H, Holzemer W.L. (1998). Adherence to antiretroviral therapy : A jour country comparaison. 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3 [Abstract #60129]
Goodwin D.L., Insull W., Jr, Russel M.L., Probstfield J.L. (1990). Predicting adherence to prescribed regimens using the health perceptions questionnaire (HPQ). In: S.A. Shumaker, E. Shron, J.K. Ockene, et al. (Eds.), The Handbook of health behavior change (64-83), New York: Springer Publishing Co.
Gordillo V., del Amo J., Soriano V., Gonzalez-Lahoz J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13 : 1763-1769.
Gordillo V., Fernandez R., Ramiro B. et al. (1998). Towards a new approach for the assessment of adherence to therapy. Proceedings of the 12th World AIDS Conference, Geneva, Switzerland, June 28-July 3. [Abstract #32382].
Guessant S. (1999). Regularité des prises et contraintes associées : un plan personnalisé de prises des médicaments proposé à la pharmacie de l’hôpital Rothschild. Info Traitements, 64/65 : 35-36
Halkitis P.N. (1999). The Seropositive Urban Drug Injectors’ Study Team. Access to antiretroviral treatment and adherence to treatment in injecting drug users and men who have sex with men. National HIV Prevention Conference. Atlanta, USA, August. [Abstract #336].
Halkitis P.N. (1998). Advances in the treatment of HIV disease : Complexities of adherence and complications for prevention. Health Psychologist, 20 (1): 6-7,14.
Hartman P.E., Becker M.H. (1978). Noncompliance with Prescribed Regimen among Chronic Hemodialysis Patients : A method of Prediction and Educational Diagnosis. Dialysis and Transplantation, 978-989.
Haynes R.B. (1976). A critical review of the " determinants " of patient compliance with therapeitic regimens. In: D.L. Sackett, R.B. Haynes (Eds.), Compliance with therapeutic regimens (26-39), Baltimore: John Hopkins University Press.
Haynes R.B. (1979). Introduction. In R.B: Haynes, D.W. Taylor & D.L. Sackett (Eds.), Compliance in Health Care, i-15, Baltimore: John Hopkins University Press.
Haynes R.B., Mattson ME., Engebretson TO. (Eds.) (1980). Patient compliance to prescribed antihypertensive medication regimens: A report to the national heart, lung, and blood institute. Bethesda, MD: DHHS (NIH Publication, No 81-2102).
Haynes R.B., McKibbon KA., Kanani R. (1996). Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet, 348: 383-386
Haynes R.B. (1979). Determinants of Compliance : The Disease and the Mechanics of Treatment. In: R. B. Haynes, D.W. Taylor, & D. L. Sackett (Eds.), Compliance en Health Care (46-62), Baltimore: Johns Hopkins University Press.
Haubrich R.H., Little S.J. Currier J.S., et al. (1999). The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS, 13: 1099-1107.
Hefez S. (sous la direction de), (1996). Sida et Vie Psychique - Approche clinique et prise en charge. Paris: La Découverte (préface de Jonathan Mann).
Holzemer W.L., Inouye J., Brown M.A. et al. (1998). Psychological well-being and HIV adherence. 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3. [Abstract #32368].
Homedes N., Ugalde A. (2001). Improving the use of pharmaceuticals through patient and community level interventions. Soc. Sci. Med., 52(1): 99-134.
Horne R., Pearson S., Leake H. et al. (1999). Patients’belief about HAART influence adherence to antiretroviral therapy. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, September. [Abstract #588].
Horne R. (1998). Adherence to medication: a review of existing research. In: L Myers, K.Midence (Eds), Adherence to Treatment in Medical Conditions (285-310), Buffalo, NY: Hardwood.
Horwitz R.I., Horwitz S.M. (1993). Adherence to treatment and health outcomes. Archives of Internal Medicine, 153: 1863-1868.
*Hugen P.W.H., Langebeek N., Burger D.M., Zomer B., van Leusen R. et al. (2002). Assessment of Adherence to HIV Protease Inhibitors: Comparison and Combination of Various Methods, Including MEMS (Electronic Monitoring), Patient and Nurse Report, and Therapeutic Drug Monitoring. JAIDS, 30 (3): 324-334. [Abstract].
Ickovics J.R., Meisler A.W. (1997). Adherence in AIDS clinical trials: a framework for clinical research and clinical care. J. Clin Epidemiol, 50 (4): 385-391
Johnston B.E., Ahmad K., et al. (1998). Adherence to HAART among HIV-infected patients of the inner city. 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3. [Abstract #32389].
Jones A.M., Thaker H., Foley B. et al. (1998). A qualitative study on retroviral therapy : Drug compliance in IVDU patients. 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3. [Abstract #32361].
Jones J.L., Nakashima A.K., Kaplan J.E. (1999). Adherence to primary prophylaxis for pneumocystis carinii pneumonia : Results from a multi-state interview project. 39th Interscience Conference an Antimicrobial Agents and Chemotherapy. San Francisco, September. [Abstract #586].
Kammann E., Williams P., Chesney M.A., Currier J. (1999). Predictors of adherence to arithromycin prophylaxis for prevention of mycobacterium avium complex (MAC) disease. 6th Conference on Retroviruses and Opportunisctic Infections. Chicago, January. [Abstract #444].
Kaplin A., Golin C., Beck K. et al. (1999). Adherence to protease onhibitor therapy and viral load. 6th Conference on Retroviruses and Opportunistic Infections. Chicago. January [Abstract #96].
Kastrissios H., Suarez J.R., Hammer S., et al. (1998). The extent of non-adherence in a large AIDS clinical trial using plasma dideoxynucleoside concentrations as a marker. 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3. [abstract #32392].
Kemppainen J.K., Levine R.E., Mistal M. & Schmidgall D. (2001). HAART adherence in culturally diverse patients with HIV/AIDS: A study of male patients from a veteran's administration hospital in Nothern California. AIDS Patient Care and STDs, Vol. 15 (3): 117-127.
Kim H.M., Lagakos S.W. (1994). Assessing drug compliance using longitudinal marker data with application to AIDS. Statistics in Medicine, 141: 2153
Kirscht J.P., Rosenstock I.M. (1977). Patient Adherence to Antihypertensive Medical regimens. Journal of Community Health, 3: 115-124.
Kirstetter M., Rebillon M. (1999). Informer avant de traiter. Info Traitements, Numéro Spécial Observance, 64/65: 30.
Kissinger P., Cohen D., Brandon W., Rice J., Morse A., Clark R. (1995). Compliance with public sector HIV medical care. Journal of the National Medical Association, 87: 19-24.
Klaus B.D., et al. (1997). Assessing and enhancing compliance with antiretroviral therapy. Nurse Pract ., 22 (4): 211-219.
Klosinski L.E., Brooks R.N. (1998). Predictors of non-adherence to HIV combination therapies. 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3. [Abstract #32375].
Kosko D., Neff-Smith M., Kim. M. (1998). Adherence barriers to complex antiretroviral regimen: the perceptions of HIV+ women and nurses. Proceedings of the 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3, 1998. [Abstract #65/32352].
Kruse W., Rampmaier J., Ullrich G., Weber E. (1994). Patterns of drug compliance with medication to be taken once and twice daily assessed by continuous electronic monitoring in primary care. International Journal Clinical Pharmacology Therapy, 32: 453-457
Kunches L., Mazzullo J.M., et al. (1998). Educational and support needs of people living with HIV to improve adherence to HAART. 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3. [Abstract #32333].
La Greca A. (1990). Issues in adherence with pediatric regimens. Journal of pediatrics psychology, 15 (4): 423-436.
Laine C., Newschaffer C.J., Zhang D., et al. (2000). Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis. Obstetrics & Gynecology, 95 (2): 167-173.
Le Coz S., Rébillon M., Tourette-Turgis C., et al. (1998). Counseling PWAs on adherence issues. 12th international conference on AIDS. Geneva, Switzerland, June 28-July 3. [Abstract 24330].
Lerner B.H., Gulick R.M., Dubler N.N. (1998). Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV-disease. Ann Intern Med, 129: 573-578.
Leventhal H. (1993). Compliance : Theories of compliance and turning necessities into preferences : Application of adolescent health action. In: N.A. Krasnegor, L.H. Epstein, S. Bennett Johnson, S.J. Yaffe (Eds.), Developmental aspects of health compliance behavior (91-124), Hillsdale, N.J: Erlbaum.
Leventhal H., Zimmerman R., Gutmann M. (1984). Compliance : A self-regulatory perspective. In: W.D. Gentry (Ed.), Handbook of behavorial medicine (369-436), New York: Guilford
Ley P. (1981). Professional non-compliance: neglected problem. British Journal of Clinical Psychology, 20: 151-154
Lopez-Suarez A., Fernandez-Gutierrez del Amo C., et al. (1998). Adherence to the antiretroviral treatment in asymptomatic HIV-infected patients. AIDS, 12: 685-686.
Marlatt G.A., Georges W.H. (1990). Relapse prevention and maintenance of optimal health. In: S.A. Shumaker, E. Shron, J.K. Ockene et al. (Eds.), The Handbook of health behavior change (44-63), New York: Springer Publishing Co.
Marlatt G.A., Gordon J.R. (1980). Determinants of relapse: Implications for the maintenance of behavior change. In : Davidson P.O., Davidson S.M. (Eds.), Behavioral medicine: Changing health lifestyles (410-452), New York: Brunner/Mazel.
Marston M.-V. (1970). Compliance with Medical Regimens : A Review of the Literature. Nursing Research, 19(4): 312-323.
Martin J., Escobar I., Rubio R. et al. (2001). Study of the validity of a questionnaire to assess the adherence to therapy in patients infected by HIV. HIV Clinical Trials, 2 (1):31-37
Mathews W.C., Mar-Tang M., Ballard C., Colwell B., Abulhoso K., Noonan C., Barber R.E., Wall T.L. (2002). Prevalence, predictors, and outcomes of early adherence after starting or changing antiretroviral therapy. AIDS Patients Care STDS, 16 (4): 157-172. [Abstract]
Mehta S., Moore R, Graham M.M.H. (1997). Potential factors affecting adherence with HIV therapy, AIDS, 11: 1663- 1670.
Meichenbaum D., Turk D. (1987). Facilitating Treatment Adherence: A Practitioner's Guidebook. New York: Plenum Press.
Messica F. (1999). Vie sociale et observance des traitements. Le Journal du Sida, Numéro Spécial Enfances & Adolescences, 120/12 : 16-18.
Meyer D., Leventhal H., Gutmann M. (1985). Common-sense models of illness : The example of hypertension. Health Psych, 4: 115-135.
Meystre-Agustoni G., Dubois-Arber F. Cochand P. & Telenti A. (2000). Antiretroviral therapies from the patient's perspective. AIDS Care, Vol. 12 (6): 717-721
Miller L., Lui H., Beck K. et al. (1999). Providers estimates of adherence overestimate reports from medication event monitoring system (MEMS) for patients on protease inhibitors. 6th Conference on Retroviruses and Opportunistic Infections. Chicago, January [abstract # 97].
Miller N.H., Hill M., Kottke T., et al. (1997). The multilevel compliance challenge: Recommendations for a call to action. Circulation, 95: 1085-1090.
Ministère de l’Emploi et de la Solidarité (1999). Accompagnement des personnes atteintes par l’infection à VIH. Pour une meilleure adhésion aux traitements antirétroviraux. Paris: CFES, Collection VIH-sida
Mitty J.A., Stone V.E., Sands M., Macalino G. and Flanigan T. (2002). Directly Observed Therapy for the treatment of people with human immunodeficiency virus infection: A work in progress. Clinical Infectious Disease, 34: 984-990. [Abstract]
Moatti J.P., Spire B.(2000). Living with HIV /AIDS and adherence to antiretroviral treatments. In : Moatti et al. (Eds.), AIDS in Europ, new challenges for the social sciences (57-73), London: Routledge.
Moatti J.P., Carrieri M.P., Spire B. et al. (2000). Adherence to HAART in French HIV-infected injecting drug users : the contribution of buprenorphine drug maintenance treatment. AIDS, Vol. 14 (2): 151-155.
Moatti J.P., Spire B. (2000). Au-delà de l’observance - Les recherches socio-comportementales sur l’impact des multithérapies antirétrovirales. Transcriptase, 83: 21-25.
Moatti J.P., Spire B., Duran S. (2000). Un bilan des recherches socio-comportementales sur l’observance des traitements dans l’infection à VIH : au-delà des modèles biomédicaux ? Revue Epidémiologique et Santé Publique, 48: 182-197.
Moatti J.P., Morin M. (1993). L'adhérence des patients : un défi aux protocoles. Le Journal du SIDA, 54-55: 20-23.
Moralez R., Figueiredo V.M., Sinkoc M.C.B. et al.. (1998). Adherence of patients with AIDS to treatment with antiretroviral medications : Difficulties related and proposition of attenuating measures. 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3. [abstract #42442].
Morgenstern T.T., Grimes D.E., Grimes R.M. (2002). Assessment of readiness to initiate antiretroviral therapy. HIV Clinical Trials, 3 (2): 168-172. [Full Text]
Morin M. (2001). De la recherche à l'intervention sur l'observance thérapeutique : contributions et prespectives des sciences sociales. In : Ed. ANRS : L'observance aux traitements contre le VIH : Mesure, déterminants, évolution. Collection Sciences Sociales et Sida, Décembre 2001: 5-20.
Morin M. (1998b). Prise en charge thérapeutique du SIDA et observance. Bulletin de l'ANRS, 24: 49-52.
Morin M., Moatti J.P. (1998). Observance et essais thérapeutiques : obstacle psychosociaux dans la recherche sur le traitement de l'infection par le VIH. Natures Sciences Sociétés, 4 (3): 228-240.
Morin M., Souville M., & Moatti J.P. (1997). L'observance des traitements antirétroviraux. In: 40e Journées de l'Hôpital Claude BERNARD - Actualité des Traitements Antirétroviraux (101-105), Paris: EDK.
Morse E.V., Simon P.M., Coburn M., et al. (1991). Determinants of Subject Compliance within an Experimental Anti-HIV Drug Protocol. Social Science and Medicine, 32(10): 1161-1167.
Morse E.V., Simon P.M., Besch C.L., Walker J. (1995). Issues of recruitement, retention and compliance in community-based clinical trials with traditionally unserserved populations. Applied Nursing Research, 8 (1): 8-14.
Mostashari F., Riley E., Selwyn P.A., Altice R.L. (1998). Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility. J. Acquir Immune Defic Synd Hum Retroviral, 18: 341-348
Moulin P. (2001). Enquête sur les pratiques des professionnels de santé en matière d'observance dans le domaine du VIH/sida en France : Recherches, actions, évaluations. In : Ed. ANRS : L'observance aux traitements contre le VIH : Mesure, déterminants, évolution. Collection Sciences Sociales et Sida, Décembre 2001: 21-31.
Muma R.D., Ross M.W., Parcel G.S., Pollard R.B. (1995). Zidovudine adherence among individuals with HIV infection. AIDS Care, Vol. 7 (4): 439-447.
Murphy D.A., Jonston Roberts K. et al. (2000). Barriers to antiretroviral adherence among HIV-infected adults. AIDS Patients Care and STDs, Vol. 14 (1): 47-58.
Murri R., Ammassari A., Gallicano K. et al. (1999). Relationship of self-reported adherence to HAART with protease inhibitor plasma level and viral load. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, September. [Abstract #593].
Murri R., Ammassari A., DeLuca A.. (1999). Definition and measurement of adherence to antiretroviral drugs in HIV-infected patients. Lancet, 353 : 1974.
Myers L., Midence K. (1998). Adherence to treatment in medical conditions. London : Hardwood Academic Press.
Myers L., & Midence K. (1998). Concepts and issues in Adherence. In : L. Myers, K. Midence (Eds.), Adherence to Treatment in Medical Conditions (1-24), London: Hardwood Academic Press.
Nagy V.T., Wolfe G.R. (1984). Cognitive predictors of compliance in chronic disease patients. Med. Care, 22: 912-921.
Nannis E.D., Temoshok L.R., Smith M., Jenkins R.A. (1993). Perceptions of AZT : Implications for adherence to medical regimens. Journal of Applied Biobehavorial Research, 1: 39-54
National Institute of Health, Office of AIDS Research (1997). Adherence to New HIV Therapies : A Research Conference. Washington, DC. November 20-21.
Nemecheck P., Tritle D. (1998). A survey evaluating pharmacy-related resources and their relation to drug adherence. 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3. [Abstract #32398].
Nurymberg K., Kreitler S., Weissler K. (1996). The congnitive orientation of compliance in short- and long-term type diabetic patients. Patient Education and Counseling, 29: 25-39.
Ohmit S., Schuman P., Schoenbaum E. et al. (1999). Adherence to antiretroviral therapy among women in the HIV Epidemiology Research Study (HERS) and Women’s Inter-Agency HIV Study (WIHS). 39th Interscience Conference on Antimicrobial Agents and Chemotheray. San Francisco, September. [Abstract #32347].
Paes A,H., Bakker A., Soe-Agnie C,J. (1998). Measurement of patient compliance. Pharm. World Sci., 20: 73-77.
Patrizia M., Carrieri C., et al. (1998). Compliance to multiple combination therapy with protease inhibitors among HIV-infected IDUs in France (cohort Manif 2000). 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3. [Abstract #32359].
Patterson D., Swindells S., Mohr J., et al. (1999). How much adherence is enough : a prospective study of adherence to protease inhibitor therapy using MEMS Caps. 6th Conference on Retroviruses and Opportunistic Infections. Chicago, January. [Abstract # 092].
Pontali E., Feasi M., Toscanini F., Bassetti M., De Gol P., Nuzzolese A., Bassetti D. (2001). Adherence to combination antiretroviral treatment in children. HIV Clinical Trials, 2(6): 466-473. [Full Text]
Pratt R., Robinson N., Loveday H.P., et al. (1998). Improvement in sexual drive and a failing viral load are associated with adherence to antitrroviral therapy. 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3. [Abstract #32343].
Probstfield J.L. (1989). Adherence and its management in clinical trials: Implications for arthritis treatment trials. Arthr. Care and Res., 2 (3): S48-S57.
Probstfield J.L., Russell M.L., Henske J.C., et al. (1986). Successful Program for Recovery of Dropouts to a Clinical Trial. Am J of Med, 80(May): 777-784.
Proctor V.E., Tesfa A., Tompkins D.C. (1999). Barriers to adherence to Highly active antiretroviral therapy as expressed by people living with HIV/AIDS. AIDS Patient Care and STDs, Vol. 13 (9): 535-544.
Project Inform (1997). Adherence to HAART : Discussion paper. N°8.
Prochaska J.O., DiClemente C.C., Norcross J.C. (1992). Search of how people change : applications to addictive behaviors. American Psychologist, 47 (9): 1102-1114.
Ragsdale D., et al. (1995). Health locus of control among HIV-positive indigent women. Journal of the Association of Nurses in AIDS Care, 6 (5): 29-36.
Raven B. (1974). The comparative Analysis of Power and Power Preference. In: J.R Tedeschied., Power and Influence (127-145), New York: Atherton.
Rébillon M., Tourette-Turgis C. (1999). La prise en charge des séropositifs en grande difficulté sociale : reportage à San Francisco dans un centre expérimental sur l’observance. Info Traitements,73: 10-12.
Report from Adherence to New HIV Therapies: A Research Conference Sponsored by the Forum for Collaborative HIV Research, The National Minority AIDS Council, and the NIH Office of AIDS Research (www.nih.gov/od/oar)
Reynnolds N.R. (1998). Initiatives to get HIV-infected patients to adhere to treatment regimens. Drug Benefits Trends, 10 (11): 23-25, 29-30, 32
Roter D.L., Hall J.A., Merisca R., et al. (1998). Effectiveness of interventions to improve patient compliance. A meta-analysis. Medical Care, 36 (8): 1138- 1161.
Roth H.P., et al. (1970). Measuring Intake of a Prescribed Medication. Clinical Pharmacology Therapy, 11: 228.
Royon L. (1999). Trithérapies : inventons la vie qui va avec ! Info Traitements, Numéro Spécial Observance, 64/65: 51-52.
Rudd P., Ahmed S., Zachary V., Barton C., Bonduelle D. ( 1992). Issues in patient compliance: The search for therapeutic sufficiency. Cardiology, 80 (Suppl. 1): 2-10.
Sackett D.L., Haynes R.B,. Gibson F.S., Taylor D.W., et al. (1978). Patient compliance with antihypertensive regimens. Patients Counseling and Health Education, 1: 18-21
Sackett D. L., & Haynes R. B. (1976). Compliance with therapeutic regimens. Baltimore: Johns Hopkins University Press.
Sackett D.L. (1976). The magnitude of compliance and noncompliance. In: D.L. Sackett, R.B. Haynes (Eds.), Compliance with therapeutic regimens (9-25), Baltimore: Jonhs Hopkins University Press.
Samet J.H., Libman H., Steger K.A., Dhawan R.K., et al. (1992). Compliance with Zidovudine therapy in patients infected with Human Immunodeficiency Virus, type 1: A cross-sectional study in a municipal hospital clinic. American Journal of Medicine, 92: 495-502.
Samuels J.E., Hendrix J., Hilton E., Marantz P.R., et al. (1990). Zidovudine therapy in an inner city population. Journal of Acquired Immune Deficiency Syndromes, 3(9): 877-883.
Schilder A.J., Hogg R.S., Goldstone I., et al. (1998). Adult social identity is part of culturally competent HIV care for sexual minorities and affects care-seeking behaviors and therapeutic adherence. 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3. [Abstract #32355].
Senak M. (1997, June). Predicting antiviral compliance : Physicians'responsabilities vs patients'rights. Journal of the International Association of Physicians in AIDS Care, 45-48.
Shea S., Misra D., Ehrlich M.H., Field L., Francis C.K. (1992). Correlates of non-adherence to hypertension treatment in an inner-city minority population. American Journal of Public Health, 82 (12): 1607-1612.
Sherr L. (2000). Adherence-Sticking to the evidence. AIDS Care, 12 (4): 373-375.
Singh N., Squier C. et al. (1996). Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus : propspective assessment with implications for enhancing compliance. AIDS Care, Vol. 8 (3): 261-269
Sorensen J.L., Chesney M.A., et al. (1998). Medication adherence strategies for drug abusers with HIV disease. AIDS Care, Vol. 10 (3): 297-312.
Souteyrand Y. (1999). Les initiatives de l’ANRS sur l’observance : quatre projets d’étude des facteurs déterminants de l’observance aux traitements sont en cours. Info Traitements, 64/65: 4.
Souville M., Morin M. (1999). Observance thérapeuptique et VIH/SIDA : un bilan rapide sur les recherches en France. InfoTraitements (Numéro Spécial Observance), 64/65: 5-7.
Spire B., Duran S., Souville M., Leport C., Raffi F., Moatti J.P., APROCO cohort study group. (2002). Adherence to highly antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Soc. Sci. Med., 54 (10): 1481-1496. [Abstract]
Spire B., Duran S., Carriéri P. et al. (2001). Les ruptures d'observance au cours du temps dans les cohortes APROCO et MANIF2000. In : Ed. ANRS : L'observance aux traitements contre le VIH : Mesure, déterminants, évolution. Collection Sciences Sociales et Sida, Décembre 2001: 87-98.
Spire B., Duran S., Souville M. et al. (2001). L'observance aux multithérapies des personnes infectées par le VIH : de l'approche prédictive à l'approche dynamique. In : Ed. ANRS : L'observance aux traitements contre le VIH : Mesure, déterminants, évolution. Collection Sciences Sociales et Sida, Décembre 2001: 43-54.
Spire B., Tourette-Turgis C. (1999). La formation des personnes traitées comme outil de motivation au soin. Le no man’s land des questions sans réponses. Info Traitements ( Numéro Spécial Observance), 64/65: 37-38.
Springer E. (1991). Effective AIDS prevention with active drug users: the harm reduction model. Journal of Chemical Dependency Treatment, 4 (2): 141-157
Spruhan J.B. (1996). Beyond traditional nursing care : cultural awareness and successful home healthcare nursing. Home Healthcare Nurse, 14 (6): 444-449.
Steckel S., Swain M. (1977). Contracting with patients to improve compliance. Hospitals, 51: 81.
Stone V.E., Hogan J.W., Schuman P. et al. (2001). Antiretroviral regimen complexity, self-reported adherence, and HIV patients'understanding of their regimens: survey of women in the HER study. JAIDS, 28: 124-131
Stone V.E., Adelson-Mitty J., Duefield C.A., et al. (1998). Adherence to protease inhibitor therapy in clinical practice : usefulness of demographics, attitudes, and knowledge as predictors. 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3. [Abstract #32337].
Stone V.E., Clark J., Lovell J. et al. (1998). HIV/AIDS patients’perspectives on adhering to regimens containing protease inhibitors. J. Gen Intern Med., 13 : 586-593.
Strathdee S.A., Palepu A., Cornelisse P.G., et al. (1998). Barriers to use of free antiretroviral therapy in injection drug users. JAMA, 280: 547-549.
Svarstad B.L., Chewning B.A., Sleath B.L., Claesson C. (1999). The brief medication questionnaire : a tool for screening patient adherence and barriers to adherence. Patient Education and Counseling, 37: 113-124.
Svarstad B. (1976). Physician-patient communication and patient conformity with medical advice. In: Mechanic D. (Ed.), The growth of bureaucratic medicine. New York: Wiley.
Tarquinio C., Fisher G.N. (2001). Dimensions conceptuelles et facteurs psycho-sociaux de la Compliance. Les Cahiers Internationaux de Psychologie Sociale, 49: 15-33.
Teeter T. (1999). Adherence : working with homeless populations. FOCUS, 14 (2): 6-12.
Tourette-Turgis C., Pereira-Paulo L., Rébillon M. (2002). Coopération Nord/Sud - L'arrivée des antirétroviraux: une économie sociale et familiale pertubée, une confrontation à d'impossibles dilemmes. Le Journal de la Démocratie sanitaire, 146: 24-28. [html] [pdf]
Tourette-Turgis C., Rebillon M. (2001). Infection par le VIH - Accompagnement et suivi des personnes sous traitement antirétroviral. Paris: Comment Dire. (cf. Chapitre 2 sur l'observance thérapeutique, pp. 8-22)
Tourette-Turgis C. (1999). Les études anglo-saxonnes sur l'observance. InfoTraitements (Numéro Spécial Observance), 64/65: 8-11.
Tourette-Turgis C., Jaeger B. (1999). Travailler sur la relation de la personne à son traitement : comment gérer la contradiction entre la nécessité de se traiter et les effets secondaires des médicaments. Info Traitements (Numéro Spécial Observance), 64/65: 22-24.
Tourette-Turgis C. (1999). Aide au patient : quelles stratégies ? Info Traitements (Numéro Spécial Observance), 64/65: 45-46.
Tourette-Turgis C., Rebillon M. (1999). Observance des traitements antiretroviraux au sein d'une population communautaire atteinte du VIH et suivie dans une pharmacie de ville. Rapport d'étude : Analyse des données issues d’entretiens qualitatifs, Comment Dire, Novembre 1999.
Tourette-Turgis C., Leiphart J.M. & Shanti Project. (1999). Medication Adherence Counseling (MAC) project : Psycho-social Counseling Program for people living with HIV/AIDS to increase adherence to medication protocols.Document interne à Shanti Project.
Tourette-Turgis C. (1998). Programme d’aide aux patients - Expérience chez les patients séropositifs : la conduite d’entretien sur l’observance. Résumé des communications de la 2ème Journée Avancées VIH organisée par GlaxoWellcome, Paris, 14 mai. [chapitre 9].
Tourette-Turgis C. (1998). L'observance, un facteur clé de succès dans les traitements des maladies chroniques. Réseaux Hépatites , 8: 14-16
Trostle J.A. (1988). Medical compliance as an ideology. Soc. Sci. Med., 27 (12): 1299-1308.
Tuldra A., Fumaz C. R., Ferrer M. J., et al. (2000). Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, 25(3): 221-228.
Tuldra A., Fumaz C.R., Ferrer M.J et al. (1999). A specific intervention improves long-term adherence to HAART and ensuing virological outcomes. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, September. [Abstract #595].
Turner J.G., Nokes K.M., Corless I.B. et al. (1998). History of drug use and adherence in HIV+ persons. 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3. [Abstract #32366].
Vanhove G.F., Schapiro J.M., Winters M.A., et al. (1996). Patient compliance and drug failure in protease inhibitor monotherapy. JAMA, 276: 1955-1956.
Wagner J.H., Justice A.C., Chesney M., Sinclair G. et al. (2001). Patient- and provider-reported adherence: toward a clinically useful approach to measuring antiretroviral adherence. Journal of Clinical Epidemiology, 54: S91-S98.
Wall T.L., Sorensen J.L., Balki S.L., Delucchi K.L., London J.A., Chesnay M.A. (1995). Adherence to zidovudine (AZT) among HIV-infected methadone patients: A pilot study of supervised therapy and dispensing compared to usual care. Drug and Alcohol Dependance, 37: 261-269.
Wallston K.A., Wallston B.S. (1978). Health Locus of Control. Health Education Monographs, 6: 101-170.
Webster R.D., Barr D. (1999). Adherence to HAART among individuals with HIV/AIDS : a compendium of HAART adherence research. Proceeding at the Forum for collaborative HIV research, Washington, D.C., Nov. 15&16. (24 p.)
Weidle P.J., Ganea C.E., Ernst J., et al. (1998) Multiple reasons for non-adherence to antiretroviral medications in an inner-city minority population : Need for a multi-faceted approach to improve adherence. 12th World AIDS Conference. Geneva, Switzerland, June 28-July 3. [abstract #32375].
Weust J. (1993). Removing the shackles : A feminist critique of non compliance. Nursing outlook, 41 (5): 217-224.
Williams A., Friedland G. (1997). Adherence, compliance and HAART. AIDS Clin Care, 9: 51-55.
Williams A., Wolf H., Yu C., et al. (1998). Adherence to antiretroviral therapy among HIV positive women. Proceedings of the 12th World AIDS Conference, Geneva, Switzerland, June 28-July 3. [Abstract #32374].
Wilson W., Ary D.V., Biglan A. (1986). Psychosocial predictors of self-care behaviors (compliance) and glycemic control in non-insulin-dependent Diabetes Mellitus. Diabetes Care, 9 (6): 614-622.
Woodward J., Wareham P.S. et al. (1998). Protease inhibitor adherence and HIV-1 RNA response. 12th World AIDS Conference.Geneva, Switzerland, June 28-July 3. [Abstract #60363].
Wright M.T. (2000). The old problem of adherence : research on treatment adherence and its relevance for HIV/AIDS. AIDS Care, Vol. 12 (6): 703-710
Zweben J.E. (1998). Addressing substance abuse in clients with psychiatric disorders and HIV disease. In: J.E. Zweben, P. Denning (Eds..), The Alcohol and Drug Wildcard: Substance use and psychiatric problems in people with HIV (312-332), UCSF AIDS Health Project. San Francisco, CA.
Abularach S., Anderson J. (2001). Gynecologic problems. In : A guide to the clinical care of women with HIV/AIDS., chapt. 5. U.S. Department of Health and Human Services, Health Resources and Services Administration (2001, First edition).Anderson R. (2001). A guide to the clinical care of women with HIV/AIDS. U.S. Department of Health and Human Services, Health Resources and Services Administration. (2001, First edition).
Arnaudiès M. (1998). Infection à VIH : les priorités de la prévention 1998/2000 – Mise en place d’une stratégie de réduction des risques sexuels en direction des femmes. Rapport pour la DGS, 16 p.
Berer M. (1994). (sous la direction de). Les femmes et le VIH/SIDA. Londres: Women and HIV/AIDS Project.
Bennett-Murphy L.M., Koranyl K., et al. (1999). Disclosure, stress, and psychological adjustment among mothers affected by HIV. AIDS Patient Care and STDs, Vol. 13 (2) : 111-118.
Cheever L.W. (2001). Adherence to HIV therapies. In : A guide to the clinical care of women with HIV/AIDS., chapt. 5. U.S. Department of Health and Human Services, Health Resources and Services Administration (2001, First edition).
Da Paz E. (1999). Femmes et infection à VIH : Enjeux d’hier et d’aujourd’hui. In : Ministère de l’Emploi et de la Solidarité (Ed.), Actes du Colloque «Femmes et infection à VIH en Europe » (21-23), Paris: CFES, Collection VIH-sida.
Da Paz E. (1999). Les services téléphoniques : A l'écoute des Femmes. In : Ministère de l’Emploi et de la Solidarité (Ed.), Actes du Colloque « Femmes et infection à VIH en Europe » (35-39), Paris: CFES, Collection VIH-sida.
Dodds S., Blaney N.T., Nuehing E.M., Blakley T. et al. (2000). Integrating mental health services into primary care for HIV-infected pregnant and non-pregnant women: Whole life - A theoretically derived. Model for clinical care and outcomes assessment. General Hospital Psychiatry, 2: 251-260.
Doyal L., Naidoo J., Wilton T. (1994). AIDS - Setting a Feminist Agenda. Londres, Taylor & Francis.
Elias C., Coggins C. (2001). Acceptability research on Female-controlled barrier methods to prevent heterosexuel transmission of HIV: Where have we been ? Where are we going ? Journal of Women'sHealth & Gender-based medicine, Vol. 10 (2): 163-173.
Galland I. (1999). Témoignages de femmes séropositives. Le journal du Sida, Numéro Spécial Enfances & Adolescences, 120/121: 31-32.
Gollub E., French P., Latka M., et al. (2001). Achieving safer sex reduction with choice: Studying a women's sexual risk reduction hierarchy in an STF clinic. Journal of Women's Health & Gender-based medicine, Vol. 10 (8): 771-783.
Gollub E. (2000). The female condom: Tool for women's empowerment. Am J Public Health, 90: 1377
*Kanshana S., Simonds R.J. (2002). National program for preventing mother–child HIV transmission in Thailand: successful implementation and lessons learned. AIDS, 16 (7): 953-959. [Abstract].
Kimerling R., Armistead L., Forehand R. (1999). Victimization experiences and HIV infection in women : associations with serostatus, psychological symptoms, and health status. Journal of Traumatic Stress, Vol. 12 (1): 41-55.
Laine C., Newschaffer C.J., Zhang D., et al. (2000). Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis. Obstetrics & Gynecology, 95 (2): 167-173.
Ministère de l’Emploi et de la Solidarité (1999). Femmes et Infection à VIH en Europe. Actes du colloque des 14/15 nov. 1997 à Paris. Paris: CFES, Collection VIH-sida.
Moser K.L., Sowell R.L., Phillips K.D. (2001). Issues of women dually diagnosed with HIV infection and substance use problems in the Carolinas. Issues in Mental Health Nursing, 22: 23-49.
Schneider B.E., Stoller N.E. (1995). Women resisting AIDS : feminist strategies of empowerment. Philadelphia: Temple University Press.
Simoni J.M., Mason H.R.C., Marks G., et al. (1995). Women’s self-disclosure of HIV infection : Rates, reasons, and reactions. Journal of Consulting and Clinical Psychology, Vol. 63 (3): 474-478.
Stevens P.E., Tighe Doerr B. (1997). Trauma of discovery : women’s narratives of being informed they are HIV-infected. AIDS Care, Vol. 9 (5): 523-538.
Stone V.E., Hogan J.W., Schuman P. et al. (2001). Antiretroviral regimen complexity, self-reported adherence, and HIV patients'understanding of their regimens: survey of women in the HER study. JAIDS, 28: 124-131
Théry I. (1999). « Une femme comme les autres » - Séropositivité, sexualité et féminité. In : Séropositivité, vie sexuelle et risque de transmission du VIH (113-136). ANRS, Collection Sciences Sociales et Sida.
Tourette-Turgis C. (1990). Les aspects psychosociaux du versant féminin de l'infection à VIH. In : Études psychothérapeutiques : désir d’enfant (59-68). Paris: Centurion.
Tuomala R.E., Shapiro D.E., Mofenson L.M., Bryson Y., Culnane M., Hughes M.D., O'Sullivan M.J., Scott G., Stek A.M., Wara D., Bulterys M. (2002). Antiretroviral therapy during pregnancy and the risk of an adverse outcome. The New England Journal of Medecine, 346 (24): 1863-1870. [Abstract]
Wang C., Celum C. (2001). HIV prevention. In : A guide to the clinical care of women with HIV/AIDS., chapt. 3. U.S. Department of Health and Human Services, Health Resources and Services Administration (2001, First edition).
Brieger W.R., Delano E., Lane C.G., Olapedo O., Oyediran K.A. (2001). West African Youth Initiative : outcome of reproductive health education program. Journal of Adolescent Health, 29: 436-446.
Card J.J. (1999). Teen pregnancy prevention: Do any programs work? Annu. Rev. Public Health., 20: 257-285.
Courpotin C. (1999). Les antirétroviraux chez l'enfant. Le journal du Sida (Numéro Spécial Enfances, adolescences), 120/121: 9-13.
Courpotin C., Rebillon M. (1999). Gérer le refus du traitement chez l’enfant. Info Traitements (Numéro Spécial Observance), 64/65: 28-29.
Courpotin C. (1999). Echappement thérapeutique chez des patients adolescents. Action, 63: 10-11.
Crosby R., DiClemente R.J., Wingood, G.M., Sionean C., et al. (2001). Correct condom application among African-American adolescent females : The relashionship to perceived self-efficacy and the association to confirmed STDs. Journal of Adolescent Health, 29: 194-199.
Delcroix S., Floury D. (1999). Les carences de l'accueil en milieu scolaire. Le journal du Sida (Numéro Spécial Enfances & adolescences), 120-121: 25-27.
Fortenberry J.D., Tu W., Harezlak J., Katz B.P. (2002). Condom use as a function of time in new and established adolescent sexual relationships. American Journal of Public Health, 92 (2): 211-213. [abstract]
Funck-Brentano I., Maraschin J. (1999). Dédramatisation de la maladie chez les enfants infectés. Le Journal du Sida (Numéro Spécial Enfances & Adolescences), 120/121: 19-20.
Goodenow C., Netherland J., Szalacha L. (2002). AIDS-related risk among adolescent males who have sex with males, females, or both: Evidence from a statewide survey. American Journal of Public Health, 92 (2): 203-210. [abstract]
Hansen W.B., Paskett E.D., Carter L.J. (1999). The adolescent sexual activity index (ASAI): a standardized strategy for measuring interpersonnal heterosexuel behaviors among youth. Health Education Research, 14 (4): 485-490. [abstract]
Hefez S., Delmotte H. (1999). Adolescence, le poids du secret. Le journal du Sida (Numéro Spécial Enfances & Adolescences), 120/121: 28-29.
Jesu F., Delmotte H. et Maraschin J. (1999). Droits de l’enfant et infection par le VIH. Le journal du Sida (Numéro Spécial Enfances & Adolescences), 120/121: 41-42.
Kim Y.L., Kols A., Nyakauru R., Marangwanda C, Chibatamoto P. (2001). Promoting sexual responsability among young people in Zimbabwe. International Family Planning Perspectives, 27 (1): 11-19.
Kirby D. (2001). Understanding what works and what doesn't work in reducing adolescent sexual risk-taking. Family Planning Perspectives, Vol 33 (6), November/december 2001.
Kressmann L. (1999). L’accueil de l’enfant en collectivité. Le Journal du Sida (Numéro Spécial Enfances & Adolescences), 120/121: 23-24.
Lipson M. (1994). Disclosure of diagnosis to children with Human Immunodeficiency or Acquired Immunodeficiency Syndrome. Developmental and Behavorial Pediatrics, Vol.15 (3) : S61-S65.
Lot F. (2000). Situation épidémiologique en France et en Europe - Diminution du nombre d’enfants infectés. Transcriptase, 81: 24-27.
Nahom D., Wells E., Rogers Gillmore M., Hoppe M., et al. (2001). Differences by gender and sexual experience in adolescent sexual behavior : Implications for education and HIV prevention. Journal of School Health, Vol. 7 (4): 153-158.
Nicolas J., Sousa A. (1999). La qualité de vie des enfants affectés. Le Journal du Sida (Numéro Spécial Enfances & Adolescences), 120/121: 21-22.
Pontali E., Feasi M., Toscanini F., Bassetti M., De Gol P., Nuzzolese A., Bassetti D. (2001). Adherence to combination antiretroiviral treatent in children. HIV Clinical Trials, 2(6): 466-473. [Full Text]
Rotherman-Borus M.J., Lee M.B., Murphy D.A., et al. (2001). Efficacy of a preventive intervention for youths living with HIV. American Journal of Public Health, 91 (3): 400-405.[abstract]
Russel S.T., Joyner K. (2001). Adolescent sexual orientation and suicide risk : Evidence from a national study. American Journal of Public Health, 91 (8): 1276-1281. [abstract]
Schultz J.R., Butler R.B., McKernan L., Boelsen R. (2001). Developing theory-based risk reduction risk interventions for HIV-positive young people with haemophilia. (2001). Haemophilia, 7 (1): 64-71. [abstract]
Siegel D.M., Aten M.J., Enharo M. (2001). Long-term effect of a middle school- and high school- based human immunodeficiency virus sexual risk prevention intervention. Arch. Pediatr Adolesc Med., Vol 133 : 1117-1126.
Broers B, Morabia A, et al. (1998). A Cohort Study of Drug Users' Compliance with Zidovudine Treatment. Arch. Intern. Med., 154(10): 1121-7.
Carrieri M.P., Moatti, J.P., Vlahov D., et al. (1999). Access to antiretroviral treatment among French HIV infected drug users: the influence of continued drug use. Epidemiology & Community Health, 53 (1): 4-8.
Ciraulo D.A., Shader R.I., Greenblatt D.J. & Creelman, W. (1989). Drug Interactions in Psychiatry. Baltimore: Williams & Williams, .
Cohen J., Shamroth A. (1990). The Challenge of Illicit Drug Addiction in General Practice. Drug and Alcohol Dependency, 25: 315-318.
Des Jarlais D.C, Hagan H, Friedman S.R, et al. (1995). Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA, 274 (15): 1226-31
Emmanuelli J. (2000). Contribution à l'évaluation de la politique de réduction des risques : Les grandes tendances (Tome 1). Edité par l'Institut de Veille Sanitaire (St Maurice, France).
Emmanuelli J. (2000). Contribution à l'évaluation de la politique de réduction des risques : Approche détaillée à l'usage des acteurs de terrain (Tome 2). Edité par l'Institut de Veille Sanitaire (St Maurice, France).
Escaffre N., Morin M., Bouhnik. A.D. (2000). Injecting drug users'adherence to HIV antiretroviral treatments: physicians'beliefs. AIDS Care, 12 (6): 723-730.
Geidel J.M., Bary M., Djuric M. (1999). Substituer : Etat des lieux pour mieux traiter. Swaps, 13: 2-4.
Grella C.E, Anglin M.D, Wugalter S.E. (1995). Cocaine and crack use and HIV risk behaviors among high-risk methadone maintenance clients. Drug and Alcohol Dependence, 37: 15-21.
Jean-Louis E., Walker J., Apollon G., Piton J. et al. (2000). Drug and Alcohol Use Among Boston's Haitian Community: A Hidden Problem Unveiled by CCHER's Enhanced Innovative Case Management Program. In : G.J. Huba (Ed.) Evaluating HIV/AIDS Treatment Programs, Innovative Methods and Findings (107-122). The Haworth Press.
Lurie P. & Drucker E. (1997). An opportunity lost: HIV infections associated with lack of anational needle-exchange programme in the USA. The Lancet, Vol. 349, No. 9052: 604- 608.
O'Brian C.P., Mc Lellan A.T. (1996). Myths about the treatment of addiction. Lancet, 237: 237-240.
Moatti J.P., Carrieri M.P., Spire B. et al. (2000). Adherence to HAART in French HIV infected injecting drug users : the contribution of buprenorphine drug maintenance treatment. AIDS, Vol. 14 (2): 151-155.
Morrill A.C., Kasten L., Urato M., Larson J. (2001). Abuse, addiction, and depression as pathways to sexual risk in women and men with history of substance abuse. Journal of Substance Abuse, 13: 169-184.
Moser K.L., Sowell R.L., Phillips K.D. (2001). Issues of women dually diagnosed with HIV infection and substance use problems in the Carolinas. Issues in Mental Health Nursing, 22: 23-49.
Rees V., Saitz R., Horton N.J., Samet J. (2001). Association of alcohol consumption with HIV sex- and drug-risk behaviors among drug users. Journal of Substance Abuse Treatment, 21: 129-134.
Sorensen J.L., Chesney M.A., et al. (1998). Medication adherence strategies for drug abusers with HIV disease. AIDS Care, Vol. 10 (3) : 297-312.
Taeron C. (2002). Conseil national du sida : il ne peut y avoir de véritable politique de réduction des risques sans réforme de la loi de 1970. Le Journal de la Démocratie sanitaire, N° 142 : 15-18.
Timpson S.C., Pollak K.I., Bowen M.L., Ross M.W. (2001). Gender differences in the processes of change for condom use: patterns across stages of change in crack cocaine users. Health Education Research, Vol. 16 (5): 541-553.
Wilson P., Watson R. & Ralston GE. (1995). Supporting Problem Drug Users: Improving Methadone Maintenance in General Practice. British Journal of General Practice, 45 (398): 454-455.
PREVENTION / REDUCTION DES RISQUES / DEPISTAGE
*Campbell C., MacPhail C. (2002). Peer education, gender and the development of critical consciousness: participatory HIV prevention by South African youth. Social Science & Medicine, 55 (2): 331-345. [Abstract].
Campbell C., Mzaidume Z. (2001). Grassroots participation, peer education, and HIV prevention by sex workers in South Africa. American Journal of Public Health, Vol. 91 (12) : 1978-1986 [abstract]
*Capaldi D.M., Stollmiller M., Clark S., Owen L.D. (2002). Heterosexual risk behaviors in at-risk young men from early adolescence to young adulthood: prevalence, prediction, and association with STD contraction. Developmental Psychology 2002, 38 (3): 394-406. [Abstract].
Chng C.L., Collins J.R. (2000). Providing culturally competent HIV prevention programs. American Journal of Health Studies, 16 (1): 24-33.
[Full Text]Cotten-Oldenburg N.U., Simon Rosser B.R., DeBoer J., et al. (2001). Building strong linkages across the HIV prevention continuum: the practical lessons learned from a comprehensive evaluation effort in Minnesota. AIDS Education and Prevention, 13 (1): 29-41
*Crosby R., DiClemente R.J., Holtgrave D.R., Wingood G.M. (2002). Design, measurement, and analytical considerations for testing hypotheses relative to condom effextiveness against non-viral STIs. Sex Transm Infect, 78: 228-231.
*Des Jarlais D.C., Semaan S. (2002). HIV Prevention Research: Cumulative Knowledge or Accumulating Studies?
An Introduction to the HIV/AIDS Prevention Research Synthesis Project Supplement. JAIDS, Supplement 1, 30(0): S1-S7. [Accès au numéro online présentant l'article complet].DiClementi R.J., Funkhouser E., Wingood G., Fawal H., Holmberg S.D., Vermund S.H. (2002). Protease inhibitor combination therapy and decreased condom use among gay men. South Med J., 95(4): 421-425 [Abstract]
*Eke A, Peersman G., Semaan S., Hylton K., Kiiti N., Sweat M.D. (2002). Acquisition and Review of Non-U.S.–Based HIV Risk Reduction Intervention Studies. JAIDS, 30: S51-S55.[Accès au numéro online présentant l'article complet].
Elias C., Coggins C. (2001). Acceptability research on Female-controlled barrier methods to prevent heterosexuel transmission of HIV: Where have we been ? Where are we going ? Journal of Women'sHealth & Gender-based medicine, Vol. 10 (2): 163-173.
*Elwy A.R., Hart G.J., Hawkes S., Petticrew M. (2002). Effectiveness of interventions to prevent sexually transmitted infection and human immunodeficiency virus in heterosexual men. A systematic review. Arch Intern Med, 162 (16): 1818-1830. [Abstract].
Emmanuelli J. (2000). Contribution à l'évaluation de la politique de réduction des risques : Les grandes tendances (Tome 1). Edité par l'Institut de Veille Sanitaire (St Maurice, France).
Emmanuelli J. (2000). Contribution à l'évaluation de la politique de réduction des risques : Approche détaillée à l'usage des acteurs de terrain (Tome 2). Edité par l'Institut de Veille Sanitaire (St Maurice, France).
*Fenton K.A. , Chinouya M., Davidson O., Copas A. (2002). HIV testing and high risk sexual behaviour among London’s migrant African communities: a participatory research study. Sex Transm Infect, 78: 241-245. [Abstract]
Fortenberry J.D., Tu W., Harezlak J., Katz B.P. (2002). Condom use as a function of time in new and established adolescent sexual relationships. American Journal of Public Health, 92 (2): 211-213. [abstract]
Gollub E., French P., Latka M., et al. (2001). Achieving safer sex reduction with choice: Studying a women's sexual risk reduction hierarchy in an STF clinic. Journal of Women's Health & Gender-based medicine, Vol. 10 (8): 771-783.
Gollub E. (2000). The female condom: Tool for women's empowerment. Am J Public Health, 90: 1377
Gollub E., Stein Z., El-Sadr W. (1995). Short-term acceptability of the female condom among staff and patients at New York City hospital. Fam Plann Perspect, 27: 155.
Greacen T., Hefez S. Marzloff (1996). (sous la direction de). Prévention du sida en milieu spécialisé. Paris: Erès.
*Hedges L.V., Johnson W.D., Semaan S., Sogolow E. (2002). Theoretical Issues in the Synthesis of HIV Prevention Research. JAIDS, 30: S8-S14.[Accès au numéro online présentant l'article complet].
*Hobfoll S.E., Jackson A.P., Lavin J., Johnson R.J., Schroder K.E.E.E. (2002). Effects and generalizability of communally oriented HIV-AIDS prevention versus general health promotion groups for single, inner-city women in urban clinics. Journal of Consulting and Clinical Psychology, 70 (4): 950-960. [Abstract].
Hogben M., Gange S.J., HeatherWatts D., Robison E., et al. (2001). The effect of sexual and physical violence on risky sexual behavior and STDs among a cohort of HIV seropositive women. AIDS and Behavior,5 (4): 353-361.
Janssen R.S., Holtgrave D.R., Valdiserri R.O., et al. (2001). The serostatus approach to fighting the HIV epidemic: Prevention strategies for infected individuals. American Journal of Public Health, Vol. 91 (7): 1019-1024.
Kalichman S.C., Cherry C., Browne-Sperling F. (1999). Effectiveness of a Video-based motivational skills-building HIV risk-reduction intervention for inner-city African American men. Journal of Consulting and Clinical Psychology, Vol. 67 (6): 959-966.
Kalichman S.C.. (1998). Post-exposure prophylaxis for HIV infection in gay and bisexual men: implications for the future of HIV prevention. Am J Prev Med., 15: 120-127.
Kamp M.L., Fishbein M., Douglas J.M., et al. (1998). Efficacy of risk-reduction-counseling to prevent human immunodeficiency virus and sexually transmitted diseases : a randomized controlled trial. JAMA, 280 (1): 1161-1167. [Abstract]
Kim Y.L., Kols A., Nyakauru R., Marangwanda C, Chibatamoto P. (2001). Promoting sexual responsability among young people in Zimbabwe. International Family Planning Perspectives, 27 (1): 11-19.
Kirby D. (2001). Understanding what works and what doesn't work in reducing adolescent sexual risk-taking. Family Planning Perspectives, Vol 33 (6), November/december 2001.
*Kresina T.F., Flexner C.W., Sinclair J., Correia M.A., Stapleton J.T., et al. (2002). Alcohol use and HIV pharmacotherapy. AIDS Research and Human Retroviruses, 18 (11): 757-770. [Abstract].
*Leigh B.C. (2002). Alcohol and condom use. A meta-analysis of event-level studies. Sexually Transmitted Diseases, 29 (8): 476-482. [Abstract].
Lert F. (2000). Advances in HIV treatment and prevention: should treatment optimism lead to prevention pessimism? AIDS Care, Vol. 12 (6): 745-755.
*Miles K. (2002). The historical role and education of nurses for the care and management of sexually transmitted infections in the United Kingdom: 1 Role. Sex Transm Inf 2002, 78 (4): 292-297. [Abstract].
*Miles K. (2002). The historical role and education of nurses for the care and management of sexually transmitted infections in the United Kingdom: Education and training. Sex Transm Inf 2002, 78 (4): 298-301. [Abstract].
Miles S.H., Song J. (2001). Behavourial assessment for HIV prevention: a model programme design. International Journal of STD & AIDS, 12: 710-716.
Morin M. (2001). Croyances, attitudes et représentations sociales dans la prévention et le traitement de l'infection au VIH. In: M.L. Bruchon-Schweitzer, B. Quintard (Eds), Personnalité et maladie (239-258), Paris: Dunod.
*Neumann M.S., Johnson W.D., Semaan S., Flores S.A., Peersman G., Hedges L.V., Sogolow E. (2002). Review and Meta-analysis of HIV Prevention Intervention Research for Heterosexual Adult Populations in the United States. JAIDS, Supplement 1, 30 (0): S106-S117. [Accès au numéro online présentant l'article complet].
ORS, ANRS & Ministère de l'Emploi et de la Solidarité (1999). Les connaissances, attitudes, croyances et comportements face au sida en France. Evolutions 1992-1994-1998.
Paicheler G. (1997). Modèles pour l'analyse de la gestion des risques liés au VIH: liens entre connaissances et actions. Sciences Sociales et Santé, 15: 36-69
Parish K.L., Cotton D., Huszti H.C., Parson J.T. (2001). Safer sex decision-making among men with haemophilia and HIV and their female partners. (2001). Haemophilia, 7 (1): 72-81. [Abstract]
Parson J.T., Huszti H.C., Crudder S.O., et al. (2000). Maintenance of safer sexual behaviours: evaluation of a theory-based intervention for HIV seropositive men with haemophilia and their female partners. Haemophilia, 6 (3): 181-190.
Pinkerton S.D., Johnson-Masotti A.P., Holtgtrave D.R., Farnham P.G. (2002). A review of the cost-effectiveness of interventions to prevent sexual transmission of HIV in the United States. AIDS and Behavior, 6 (1) : 15-31.
Robinson BB.E. Bockting W.O., Simon Rosser B.R. Miner M., Coleman E. (2002). The Sexual Health Model : application of a sexological approach to HIV prevention. Health Education Research, 17 (1) : 43-57. [abstract]
Rosenthal D., Gifford S., Moore S. (1998). Safe sex or safe love : competing discourses ? AIDS Care, Vol. 10 (1): 35-47.
Russel S.T., Joyner K. (2001). Adolescent sexual orientation and suicide risk : Evidence from a national study. American Journal of Public Health, 91 (8): 1276-1281. [abstract]
Rutledge S.E., Roffman R.A., Picciano J.F., Kalichman S.C., Berghuis J.P. (2002). HIV prevention and attrition : challenges and opportunities. AIDS and Behavior, 6 (1) : 69-82.
Sogolow E., Peersman G., Semaan S., Strouse D., Lyles C.M.(2002). The HIV/AIDS Prevention Research Synthesis Project: Scope, Methods, and Study Classification Results. JAIDS, Supplement 1, 30 (0): S15-S29.[Accès au numéro online donnant présentant l'article complet].
Schultz J.R., Butler R.B., McKernan L., Boelsen R. (2001). Developing theory-based risk reduction risk interventions for HIV-positive young people with haemophilia. (2001). Haemophilia, 7 (1): 64-71. [abstract]
Siegel D.M., Aten M.J., Enharo M. (2001). Long-term effect of a middle school- and high school- based human immunodeficiency virus sexual risk prevention intervention. Arch. Pediatr Adolesc Med., Vol 133 : 1117-1126.
(van der) Straten A., Gomez C.A., Saul J., Quan J., Padian N. (2000). Sexual risk behavior among heterosexual HIV serodiscordant couples in the era of post-exposure prevention and viral suppressive therapy. AIDS, 14 (4): F47-54.
Taeron C. (2002). Conseil national du sida : il ne peut y avoir de véritable politique de réduction des risques sans réforme de la loi de 1970. Le Journal de la Démocratie sanitaire, N° 142 : 15-18.
Tourette-Turgis C. (2001). La prévention contre le barebacking. Info Traitements, 92: 1-3. (texte et titre originaux avant publication)
Tourette-Turgis C. (1995). La place nécessaire du sujet en prévention comme en éducation à la santé. Une présence analytique dans un centre de dépistage et de prévention du SIDA. In : Revue annuelle L'année de la Recherche en Sciences de l'Education (57-70). Paris, PUF.
Van De Ven P., Kippax S., Knos S., et al. (1999). HIV treatment optimism and sexual behaviour among gay men in Sydney and Melbourne. AIDS, 13: 2289-2294.
Wang C., Celum C. (2001). HIV prevention. In : A guide to the clinical care of women with HIV/AIDS., chapt. 3. U.S. Department of Health and Human Services, Health Resources and Services Administration (2001, First edition).
Warszawski J., Meyer L. (2002). Sex difference in partner notification: results from three population based surveys in France. Sex Transm Inf., 78: 45-49 [Full Text]
Kalichman S.C. (1998). Post-exposure prophylaxis for HIV infection in gay and bisexual men: implications for the future of HIV prevention. Am J Prev Med., 15: 120-127.
Katz M.H., Gerberding J.L. (1998). The care of persons with recent sexual exposure to HIV. Annals of Internal Medicine, Vol. 128 (4): 306-312.
Katz M.H., Gerberding J.L. (1997). Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use. New England Journal of Medecine, 336: 1097-1100.
Khan J.O., Martin J.N., Roland M.E., Bamberger J.D. et al. (2001). Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure : The San Francisco PEP study. The Journal of Infections Diseases, 183: 707-714. [abstract] [Full Text]
Lamontagne F., Pillonel J., Laporte A. et al. (2000). Enquête : Prophylaxie après exposition non professionnelle au VIH – Expérience eg attitude des médecins hospitaliers. BEH, Numéro spécial mars 2000 : 32-34
Laporte A. (2001). Prophylaxie post-exposition : les leçons de San Francisco. Transcriptase, 93: 2-6.
Lurie P., Miller S., Hecht F., Chesney M.A., Lo B. (1998). Postexposure Prophylaxis after Nonoccupational HIV exposure. JAMA, Vol. 280 (20) : 1769-1773.
Ministère de l’Emploi et de la Solidarité (1999). De la situation à risque à la prise en charge. Paris: CFES, Collection VIH-sida (document rédigé par le CRIPS Ile de France sous la responsabilité de la DGS).
van der Straten A., Gomez C.A., Saul J., Quan J., Padian N. (2000). Sexual risk behavior among heterosexual HIV serodiscordant couples in the era of post-exposure prevention and viral suppressive therapy. AIDS, 14 (4): F47-54.
Tourette-Turgis C. (1998). La place du counseling dans le traitement prophylactique de l’infection à VIH. Transcriptase, 67: 7-9.
CO-INFECTION VIH/VHC & HEPATITE C
Ménard C., Gautier A., Dressen C. (2000). Les médecins face au VIH et à l'hépatite C. In : Baromètre santé médecins généralistes 98/99 (77-88), Paris: Editions CFES.
Ministère de l'Emploi et de la Solidarité (2000). Campagne nationale d'information sur l'hépatite C et d'incitation au dépistage du VHC - [actualisation décembre 2001]
Pialoux G. (1997). Soigner le VIH et aggraver le VHC ? Swaps, 5: 12.
Rotiliy M., Vernay-Vaisse C., Rousseau S., Bourliere M. et al. (1999). Prevalence of HCV and HIV antibodies and related risk among entrants to the main southeastern french prison. Clin. Microbiol. Infect., 5: 733-739.
Tourette-Turgis C, Rébillon M. (2001). "La co-infection VIH-hépatites". In: C. Tourette-Turgis C, M. Rébillon (Eds), Infection par le VIH - Accompagnement et suivi des personnes sous traitement antirétroviral. (101-106). Paris: Comment Dire
Zylbernerg H., Pol. S. (1999). Co-infection par les virus de l’immunodéficience humaine et de l’hépatite C : données actuelles. Documents d’Information de l’ANRS, Janvier: 1-6.
Centre Européen pour la Surveillance Epidémiologique du Sida (2001). Surveillance du VIHSIDA en Europe. Rapport du 1er semestre 2001. N°65 [60 pages en format pdf]
Emmanuelli J. (2000). Contribution à l'évaluation de la politique de réduction des risques : Les grandes tendances (Tome 1). Edité par l'Institut de Veille Sanitaire (St Maurice, France)
Emmanuelli J. (2000). Contribution à l'évaluation de la politique de réduction des risques : Approche détaillée à l'usage des acteurs de terrain (Tome 2). Edité par l'Institut de Veille Sanitaire (St Maurice, France)
Institut de Veille Sanitaire (2001). Surveillance du SIDA en France : Situation au 30 septembre 2001. BEH, N°47
ONUSIDA (2001). Le point sur l'épidemie de sida-décembre 2001 [avec accès au rapport en français]
ONUSIDA (2001). Tableau récapitulatif de l'épidémie d'infection VIH/SIDA dans le monde, décembre 2001 [diapositives en français]
ASPECTS GENERAUX/PROGRAMMES NATIONAUX
*Kanshana S., Simonds R.J. (2002). National program for preventing mother–child HIV transmission in Thailand: successful implementation and lessons learned. AIDS, 16 (7): 953-959. [Abstract].
Okubagzhi G., and Singh S. (2002). Etablishing an HIV/AIDS programme in developing countries: the Ethiopan experience. AIDS 2002, 16 (12) : 1575-1586. [Abstract].
del Rio C., Sepulveda J. (2002). AIDS in Mexico: lessons learned and implications for developing countries. AIDS, 16 (12): 1445-1457. [Abstract].
Baruth L.G., Robinson E.H. (1987). An introduction to the counseling profession. Englewood Cliffs, NJ: Prentince-Hall.
Benbassat J., Baumal R. (2002). A step-wise role playing approach for teaching patient counseling skills to medical students. Patient Education and Counseling, 46 (2): 147-152. [abstract]
Brearley J. (1995). Counselling and social work. Buckingham: Open University Press.
Burnard P.. (1994). Counselling skills for health professionnals. Buckingham: Chapman & Hall.
Capuzzi D., Gross DR. (sous la direction de). (1991). Introduction to counseling : perspectives for the 1990s. Boston: Allyn and Bacon.
Chaplin J. (1988). Feminist counselling in Action. Londres: Sage Publications.
d'Ardenne P., Mahtani A. (1989). Transcultural counselling in Action. Londres: Sage Publications.
Deurzen-Smith E. van. (1988). Existential counselling in practice. Londres: Sage Publications.
Dilley James W., Pies C., Helquist M. (1989). Face to face : a guide to AIDS counseling. San Francisco: AIDS Health Project.
Dryden W., Charles-Edouard D., Woolfe R. (sous la direction de) (1989). Handbook of counselling in Britain. Londres: Routledge.
Dryden W., Thorne B. (sous la direction de) (1991). Training and supervision for counselling in Action. Londres: Sage Publications.
Dryden W.(sous la direction de) (1993). Questions and answers on counselling in Action. Londres: Sage Publications.
Dryden W., Feltham C. (1994). Developing counsellor training. Londres: Sage Punlications.
Ellis A., Harper R.A. (1992). L'approche émotivo-rationnelle (traduit de l'anglais par D. Dion). Les Editions de l'Homme.
Gazda G.M. (1984). Group Counseling : A developmental approach (3nd ed.) Boston: Allyn & Bacon
George R.L., Dustin D. (1988). Group counseling : theory and practice. Englewood Cliffs, New Jersey: Prentice-Hall.
George R.L. (1990). Counseling, The chemically dependent. Boston: Allyn and Bacon.
Gregory S., Sanjek R. (sous la direction de) (1994). Race. New Brunswick, NJ: Rutgers University Press.
Héru J.L.(1994). La relation d'aide : éléments de base et guide de perfectionnement. Québec: Gaëtan Morin.
Hill C.E., Corbett M.M. (1993). A perspective on the history of process and outcome research in counseling psychology. Journal of Counseling Psychology, 40 (1): 3-24.
Ivey A.E., Bradford Ivey M., Simek-Downing L. (1987). Counseling and psychotherapy : integrating skills, theory and practice. Boston: Allyn and Bacon.
Jacobs M. (1988). Psychodynamic counselling in Action. Londres: Sage Publications.
Kaschak E. (1992). Engendered Lives : a new psychology of women's experience.Basic Books: New York.
Klein C. (1991). Counseling our own : the lesbian/gay subculture meets the mental health system. Renton: WA, Design and production (1ère édition, 1986).
McLeod J. (1993). An introduction to counselling. Buckhingham: Open University Press.
Mearns D. (1994). Developing personn-centred counselling. Londres: Sage Publications.
Mearns D., Thorne B. (1994). Personn-centred counselling in Action. Londres: Sage Publications (1ère édition 1988).
Palmer S., Varma V. (1997). The future of counselling and psychotherapy. Londres: Sage Publications.
Patton M.J., Meara N.M. (1992). Psychoanalytic counseling. Chichester: Wiley.
Powell T.J. (1994). Understanding the self-help organization : Frameworks and findings. Londres: Sage Publications.
Rogers Carl R.. (1973) : Les groupes de rencontres. Paris: Dunod (traduction française de D. Le Bon)
Rogers Carl R.. (1968). Le développement de la personne. Paris: Bordas (traduction française de E.L. Herbert, Préface de M. Pagès).
Rogers Carl R.. (1970). Relation d'aide et psychothérapie. Paris: ESF.
Skelton A.M. (1997). Patient education for the millennium : beyond control and emancipation. Patient Education and Counseling, 3: 151-158.
Shertzer B., Stone S.C. (1968). Fundamentals of counseling. Boston: Houghton Mifflin.
Shilts R. (1991). Counseling our own : The lesbian/gay subculture meets the mental health system. Washington: Charna Klein.
Skovholt T.M., Ronnestad M.H. (1992). The evolving professional self. Chichester: Wiley.
Tourette-Turgis C.(1996). Le counseling. Paris: PUF-Coll. Que Sais-je? (n°3133)
Trower P, Casey A., Dryden W. (1988). Cognitive-behavioural counselling in Action. Londres: Sage Publications.
Veer, Guus van der. (1992). Counselling and therapy with refugees. Chichester: New York, Wiley.
Balmer D.H. (non daté, vraisemblablement 1991-92). HIV/AIDS group counselling : theory and practice. (Naresa monograph n°1) Nairobi: Naresa.
Bentz L., Pradier C., Tourette-Turgis C., Morin M., Rébillon M. et al. (2001). Description et évaluation d'un programme d'intervention sur l'observance thérapeutique (counseling) dans un centre hospitalo-universitaire. In : Ed. ANRS : L'observance aux traitements contre le VIH : Mesure, déterminants, évolution. Collection Sciences Sociales et Sida, Décembre 2001: 99-112.
Bentz L., Pradier C., Tourette-Turgis C., Rébillon M., Morin M., et al.. (2001). Impact of a counseling program on treatment adherence in HIV infected persons treated by HAART in a French University Hospital. Fifth International Conference AIDS IMPACT 2001, Biopsychosocial aspects of HIV infection, Brighton, United Kingdom, July 8-11, 2001. (Oral presentation, July 9). [diapos en anglais]
Bernard E. (1994). Décryptage de l'angoisse en deux temps et trois exemples (Dossier dépistage et counseling). Le Journal du Sida, 59: 30-31.
Bor R., Miller R., Goldman E. (1992). Theory and practice of HIV counselling. Londres: Cassell.
Britton P.J., Cimini K.T., Rak C.F. (1999). Techniques for teaching HIV counseling: An intensive Experiential model. Journal of Counseling & Develpment, Spring 1999, Vol. 77: 171-176.
Cavelier-Alzoubi A. (1993). Rendu d'un test négatif : les questions posées par un possible effet inducteur de comportements à risque. Transcriptase, 19: 19-21.
Cartoux M., Sombie I., Van de Perre P., et al. (1999). Evaluation of 2 techniques of HIV pre-test counselling for pregnant women in west Africa. DITRAME Study Group. Int. J. STD AIDS, 10 (3): 199-201.
Covadia H.M. (2000). Access to voluntary counseling and testing for HIV in developing countries. Ann. N Y Acad. Sci., 918: 57-63.
De Rosa C.J., Marks G. (1998). Preventive counseling of HIV-positive men and self-disclosure of serostatus to sex partners : new opportunities for prevention. Health Psychology, Vol. 17 (3) : 224-231.
Farham P.G., Pinkerton S.D., Holtgrave D.R., Johnson-Masotti AP. (2002). Cost-effectiveness of counseling and testing to prevent sexual transmission of HIV in the United States. AIDS and Behavior, 6 (1): 33-43
Geismar D. (1994). Le sens symbolique du test (Dossier dépistage et counseling). Le journal du Sida, 59: 29-30.
Grinstead O.A., Van Der Straten A et al. (2000). Counsellor's perspectives on the experience of providing HIV counselling in Kenya and Tanzania : the voluntary HIV-1 counselling and testing efficacy study. AIDS Care, 12 (3): 625-642.
Kamb M.L., Dillon B.A., Fishbein M., Willis K.L. (1996). Quality assurance of HIV prevention counseling in a multi-center randomized controlled trial. Public Health Report, Vol. III, Supplément 1: 99-107
Kamenga M.C., et al. (2000). The voluntary HIV-1 counselling and testing efficacy study : design and methods. AIDS and Behaviour, 4 (1): 5-14.
Kamp M.L., Fishbein M., Douglas J.M., et al. (1998). Efficacy of risk-reduction-counseling to prevent human immunodeficiency virus and sexually transmitted diseases : a randomized controlled trial. JAMA, 280 (1): 1161-1167. [abstract]
Killewo J.Z.J., Kwesigabo G., Comoro C., Lugalla J., et al. (1998). Acceptability of voluntary HIV testing with counselling in a rural village in Kagera, Tanzania. AIDS Care, Vol. 10 (4): 431-439.
Lutgendorf S., Antoni M.H., Schneiderman N,. Fletcher M.A. (1994). Psychosocial counseling to improve quality of life in HIV infection. Patient Education and Counseling, 24: 217-235.
OMS (1999). Le Conseil VIH/SIDA: un élément clé pour la prise en charge. Ed. OMS (Réf. WHO/GPA/TCO/HCS/95-15).
OMS (1994). Guide de formation au Conseil VIH/SIDA. Ed. OMS (Réf. WHO/GPA/TCO/HCS/94-9).
ONUSIDA (2000). Conseil et test volontaire (actualisation septembre 2000). Ed. ONUSIDA, Coll. Meilleures pratiques.
ONUSIDA (2000). Tools for evaluating HIV voluntary counselling and testing. Ed. ONUSIDA Coll. Meilleures pratiques.
ONUSIDA (1997). Politique de l'ONUSIDA relative au test et au Conseil. Ed. ONUSIDA (Réf. 97/2).
Painter T. M. (2001). Voluntary counseling and testing for couples: a hight-leverage intervention for HIV/AIDS prevention in sub-Saharan Africa. Social Science & Medicine, 53 (11): 1397-1411
Rebillon M. (1994). Déplacer la question (Dossier dépistage et counselling). Le journal du Sida, 59: 35
Régnier-Aeberhard F., Stephan I. (1994). A l'écoute du consultant (Dossier dépistage et counseling). Le journal du Sida, 59: 27-28
Rolland D. (1994). Préservatif : derrière un oui, les raisons de dire non (Dossier dépistage et counseling). Le Journal du Sida, 59: 32-34
Tourette-Turgis C., Rebillon M. (2002). Mettre en place une consultation d'observance aux traitements contre le VIH/sida - De la théorie à la pratique. Paris: Comment Dire.
Tourette-Turgis C. (2002). Counseling en France: des pratiques en mouvement. Transcriptase, 100: 19-22. [ Format pdf]
Tourette-Turgis C., Rebillon M. (2001). Infection par le VIH - Accompagnement et suivi des personnes sous traitement antirétroviral. Paris: Comment Dire.
Tourette-Turgis C., Quayle W. (1999). Le soutien psychologique des personnes séropositives sous traitement : le counseling. AIDS Clinical Care, vol. 11 (8) :
Tourette-Turgis C. (1998). La place du counseling dans le traitement prophylactique de l’infection à VIH. Transcriptase, 67: 7-9.
Tourette-Turgis C. (1997). Infection à VIH et trithérapies : guide de counseling. Paris: Comment Dire.
Tourette-Turgis C. (1997). Stratégies de counseling : les nouveaux enjeux du diagnostic et de la prise en charge précoce de l’infection VIH. Transcriptase, 58: 14-17.
Tourette-Turgis C. (1996). Infection à VIH - La rétinite à CMV : guide de counseling. Paris: Comment Dire.
Tourette-Turgis C. (1994). Etendre le champ d'action du counselling (Dossier dépistage et counseling). Le journal du sida, 59: 35
Tourette-Turgis C. (1993). L'émergence de courants de pensée dans le counseling. Transcriptase, 17: 35-36.
Tourette-Turgis C. (1993). Prévenir et/ou soutenir. Le Journal du Sida, 54-55: 89-90..
Tourette-Turgis C. (1992). Sida : un guide de counseling appliqué à chaque phase de l'infection à V.I.H. Transcriptase, 2: 30-31.
Tourette-Turgis C. (1992). L'essor des pratiques de counseling. Transcriptase, 8: 42-43.
Tourette-Turgis C. (1990). Le counseling : un outil, un courant d'idées, un ensemble de pratiques (Dossier counseling) Sida 90, 20: 24-28.
Tourette-Turgis C. (1990). Le counseling et l'OMS : le conseil psychosocial (Dossier counseling). Sida, 90, 20:29.
Tourette-Turgis C. (1990). Le Shanti Project : counseling en pratique (Dossier counseling). Sida 90, 20: 30-33
Weinhardt L.S., Carey M.P., Johnson B.T., Bicham N.L. (1999). Effects of HIV counseling and testing on sexual risk behavior: A meta-analytic review of published resarch, 1985-1997. American Journal of Public Health, Vol. 89 (9): 1397-1405.
PSYCHOLOGIE MEDICALE : MALADIES & MALADIES CHRONIQUES
Assal J.P. (1999). Revisiting the approach to treatment of long-term illness : from the acute to the chronic state. A need for educational and managerial skills for long-term follow-up. Patient Education and Counseling, 37: 99-111.
Assal J.P. (1996) Traitement des maladies de longue durée : de la phase aiguë au stade de la chronicité. Une autre gestion de la maladie, un autre processus de la prise en charge. Encycl. Med. Chir., 25-005-A10.
Auchincloss S.S. (1987). Sexual dysfunction in cancer patient. : Brief clinical evaluation and treatment guidelines. In : Proceedings of the workshop on psychosexual and reproductive issues affecting patients with cancer. New York : American Cancer Society.
Bello L.K., McIntire S.N. (1995). Body image disturbances in young adults with cancer. Cancer Nursing, Vol. 18 (2): 138-143.
Borgers R., Mullen P.D., Meertens R., Rijken M., et al (1993). The information-seeking behavior of cancer outpatients : a description of the situation. Patient education & Counseling, 22 :35-46
Breaden K. (1997). Cancer and beyond : the question of survivorship. Journal of Adavanced Nursing, 26: 978-984.
Crossley M.L. (1999). Stories of illness and trauma survival : liberation or repression ? Social Science & Medicine, 48: 1685-1695.
Dunbar-Jacob J., Dwyer K., Dunning E.J. (1991). Compliance with anti-hypertension regimen : A review of the research in the 1980s. Annals of Behavorial Medicine, 13: 31-39.
Dunbar-Jacob J. (1990). Predictors of patient adherence : patient characteristics. In: Shumaker SA, Shron E, Ockene JK et al. (Eds.), The Handbook of health behavior change (348-359), New York: Springer Publishing Co.
Dunbar-Jacob J., Burke L.E., Puczynski S. (1990). Clinical assessment and management of adherence to medical regimens. In S.A. Shumaker, E. Shron, J.K. Ockene, et al. (Eds.). The Handbook of health behavior change (313-339), New York: Springer Publishing Co.
Eschenbach A.C. (Von) (1981). Sexual dysfunction and rehabilitation. In: von Eschenbach AC., Rodriguez DB. (Eds.),. Sexual rehabilitation of the urologic cancer patient (9-13). Boston: G.K. Hall.
Ferrel B, Grant M., Schmidt G.M et al. (1992). The meaning of quality of life for bone marrow transplant survivors (part.2). Cancer Nursing, Vol. 15 (4): 247-253.
Folkman S., Chesney M.A., McKusick L., et al. (1991). Translating coping theory into an intervention. In : J. Eckenrode (Ed.), The social context of coping (239-259). New York: Plenum Press.
Funk S.G., Tornquist E.M., Champagne M.T. & Weise R.A. (1993). Key aspects of caring for the chronically ill: hospital and home. New York: Springer.
Galloway S.C. & Graydon J.E. (1996). Uncertainty, symptom distress, and information needs after surgery for cancer of the colon. Cancer Nursing, 19: 112-117.
Hassey Dow K., Ferrell B.R. et al. (1999). The meaning of Quality of life in cancer survivorship. Oncology Nursing Forum, Vol. 26 (3): 519-528.
Haynes R.B. (1979). Determinants of compliance : the disease and the mechanics of treatment. In: R.B. Haynes, D.L. Sackett (Eds.), Compliance in health care (49-62). Baltimore: John Hopkins University Press.
Haynes R.B. (1976). A critical review of the « determinants » of patient compliance with therapeitic regimens. In: D.L. Sackett, R.B. Haynes (Eds.), Compliance with therapeutic regimens (26-39). Baltimore: John Hopkins University Press.
Helman C.G. (1981). Diseases versus illness in general practice. Jl R. Coll. gen. Practrs, 31: 548-52.
King C.R., Ferrell B.R., Grant M., Sakurai C. (1995). Nurses’perceptions of the meaning of quality of life for bone marrow transplant survivors. Cancer Nursing, Vol. 18 (2): 118-129.
Lacroix A., Assal J.P. (1998). L’éducation thérapeutique du patient : Nouvelles approches de la maladie chronique. Paris: Vigot.
Lazarus R.S. & Folkman S. (1984). Stress, appraisal, and coping. New York: Springer Publishing Co.
Ley P. (1995). Improving patients'understanding, recall, satisfaction and compliance. In: A. Broome (Ed.), Health Psychology : Processes and applications. (Second Edition), London: Chapman.
Macquart-Moulin G., Viens P., Bouscary M.-L., et al. (1997). Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy : an issue for quality of care. British Journal of Cancer, 76(12): 1640-1645.
Mast M.E. (1995). Adult uncertainty in illness: a critical review of researh. Scholarly Inquiry for Nursing Practice: An International Journal, 9: 3-24.
McCabe M.A. (1996). Involving children and adolescents in medical decision making : developmental and clinical considerations. Journal of Pediatric Psychology, Vol. 21 (4): 505-516.
Mishel M.H. (1997). Uncertainty in chronic illness. Annual Review of Nursing Research, 15: 57-80.
Mishel M.H., Braden C.J. (1987). Uncertainty a mediator between support and adjustment. Western Journal of Nursing Research, 9: 43-57.
Mishel M.H. (1981). The measurement of uncertainty in illness. Nursing Research, 30: 258-263.
Murawski .J., Penman D., Schmitt M. (1978). Social support in health and illness : the concept and its measurement. Cancer Nursing, October : 365-371.
Power M, Bullinger M., Harper A., and the World Health Organization Quality of Life Group. (1999). The World Health Organization WHOQOL-100 : Test of the Universality of Quality of Life in 15 different cultural groups worldwide. Health Psychology, Vol. 18 (5): 495-505.
Rustoen T., Wiklund I., et al. (1998). Nursing intervention to increase hope and quality of life in newly diagnosed cancer patients. Cancer Nursing, Vol. 21 (4): 235-245.
Sackett D.L., Haynes R.B,. Gibson F.S., Taylor D.W., et al.. (1978). Patient compliance with antihypertensive regimens. Patients Counseling and Health Education, 1: 18-21
Schover L.R. (1988). Sexuality and the male cancer patient. New York: American Cancer Society.
Schover L.R. (1988). Sexuality and the female cancer patient. New York: American Cancer Society.
Slavin L. et al. (1982). Communication of the cancer diagnosis to pediatric patients : impact on long-term adjustement. Am. J. Psychiatry, 139: 179-183.
Small S., Lamb M. (1999). Fatigue in chronic illness : the experience of individuals with chronic obstructive pulmonary disease and with asthma. Journal of Advanced Nursing, Vol. 30 (2): 469-478.
*Smith T.W., Kendall P.C., Keefe F.J. (2002). Behavorial medicine and clinical health psychology: Introduction to the special issue, a view from the decade of behavior. Journal of Consulting and Clinical Psychology, 70 (3): 459-462. [Abstract].
Smith D.B. (1989). Sexual rehabilitation of the cancer patient. Cancer Nursing, Vol. 12(1): 10-15.
Spinetta J.J. (1974). The dying child’s awareness of death : A review. Psychol. Bull., 81: 256-260.
Steele R.G., Tripp G. et al. (1997). Family members’uncertainty about parental chronic illness : the relashionship of hemophilia and HIV infection to child functioning. Journal of Pediatric Psychology, Vol. 22 (4) : 577-591.
Swain M. (1978). Experimental interventions to promote health among hypertensives. Paper presented at American Psychological Association meeting, Toronto.
Waetcher E.H. (1973). Children’s awareness of fatal illness. Am. J. Nurs., 71: 1168-1172.
Wu A.W., Rubin H.R., Mathews W.C. et al. (1991). A health status questionnaire using 30 items from the medical outcomes study. Medical Care, Vol. 29 (8): 786-798.
COMMUNICATION SOIGNANTS/PATIENTS
Benbassat J., Baumal R. (2002). A step-wise role playing approach for teaching patient counseling skills to medical students. Patient Education and Counseling, 46 (2): 147-152. [abstract]
Cassel E.J. (1985). Talking with Patients, Volume2 : Clinical Technique. Oxford University Press.
Freemon B. et al. (1971). Gaps in doctor-patient communication : Doctor-patient interaction analysis. Pediatr. Res., 5: 298.
Grenier B. (1993). La décision médicale. Ed. Masson.
*Greco M., Brownlea A., McGovern J. (2001). Impact of patient feedback on the interpersonal skills of general practice registrars: results of a longitudinal study. Medical Education, 35 (8), 748-756. [Abstract].
Ley P. (1979). Memory for medical information. Br. J. Soc. Clin. Psychol., 18: 245.
Ley P. (1977). Psychological studies of doctor-patient communication. In : Rachman S. (Ed.), Contributions to Medical Psychology. Oxford: Pergamon.
Pendleton D., Schofield T., Tate P., Havelock P. (1984). The Consultation : an Approach to Learning and Teaching. The MIT Press.
Tabak N. (1995). Decision making in consenting to experimental cancer therapy. Cancer Nursing, Vol. 18 (2): 89-96.
Thompson S.C., Nanni C., Schwankovsky L.S. (1990). Patient-Oriented Interventions to Improve Communication in a Medical Office Visit. Health Psych, 9(4): 390-404